{
  "directed": true,
  "graph": {
    "annotation_list": {},
    "annotation_pattern": {
      "Species": "^\\d+$"
    },
    "annotation_url": {
      "CellLine": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-line/cell-line-20170511.belanno",
      "CellStructure": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-structure/cell-structure-20170511.belanno",
      "MeSHAnatomy": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-anatomy/mesh-anatomy-20170511.belanno",
      "MeSHDisease": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-diseases/mesh-diseases-20170511.belanno"
    },
    "document_metadata": {
      "authors": "Sandra Spalek",
      "contact": "charles.hoyt@scai.fraunhofer.de",
      "copyright": "Copyright Â© 2019 Fraunhofer Institute SCAI, All rights reserved.",
      "description": "",
      "licenses": "CC BY 4.0",
      "name": "The O-GlcNAc modification protects against protein misfolding and aggregation in neurodegenerative disease",
      "version": "1.0.0"
    },
    "namespace_pattern": {
      "PUBCHEM": "^\\d+$"
    },
    "namespace_url": {
      "CHEBI": "https://raw.githubusercontent.com/pharmacome/terminology/efc856fb009a39e4d284269a6801f79ed3d3cf56/external/chebi-names.belns",
      "CONSO": "https://raw.githubusercontent.com/pharmacome/conso/501ceccdc9a27d97edbdc48a89ebe8e1dd3626e9/export/conso-names.belns",
      "FPLX": "https://raw.githubusercontent.com/sorgerlab/famplex/d9ec0526c20795146a9a6aef17496efe1a36cac6/export/famplex.belns",
      "GO": "https://raw.githubusercontent.com/pharmacome/terminology/efc856fb009a39e4d284269a6801f79ed3d3cf56/external/go-names.belns",
      "HGNC": "https://raw.githubusercontent.com/pharmacome/terminology/efc856fb009a39e4d284269a6801f79ed3d3cf56/external/hgnc-names.belns",
      "HGNCGENEFAMILY": "https://raw.githubusercontent.com/pharmacome/terminology/efc856fb009a39e4d284269a6801f79ed3d3cf56/external/hgnc.genefamily-names.belns",
      "HP": "https://raw.githubusercontent.com/pharmacome/terminology/efc856fb009a39e4d284269a6801f79ed3d3cf56/external/hp-names.belns",
      "MESH": "https://raw.githubusercontent.com/pharmacome/terminology/efc856fb009a39e4d284269a6801f79ed3d3cf56/external/mesh-names.belns",
      "MGI": "https://raw.githubusercontent.com/pharmacome/terminology/efc856fb009a39e4d284269a6801f79ed3d3cf56/external/mgi-names.belns",
      "RGD": "https://raw.githubusercontent.com/pharmacome/terminology/efc856fb009a39e4d284269a6801f79ed3d3cf56/external/rgd-names.belns"
    },
    "namespaces_uncached": [],
    "path": "tau/ryan2019.bel",
    "pybel_version": "0.13.2"
  },
  "links": [
    {
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "The addition and removal of OGlcNAc onto protein substrates is governed entirely by two ubiquitously expressed enzymes: O-GlcNAc transferase [EC 2.4.1.255] (OGT) and O-GlcNAc hydrolase [EC 3.2.1.169] (OGA) respectively (see Figure 2).",
      "key": "86ba8c7ebe801906d9e3810f4ba949ed05a7bb1b7ad260c53420d93fcea7eeb890887faa50f936cea248437066908e275371101fb4d90a33dd0a72d73eb1de90",
      "line": 81,
      "relation": "increases",
      "source": 66,
      "target": 84
    },
    {
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "OGT-mediated transfer of O-GlcNAc onto proteins is therefore closely tied to cellular glucose concentrations, though notably glucosamine and GlcNAc may also be recycled via salvage pathways",
      "key": "df67f31a65b87d292c92491f418fe8a0e9d9d0e3a51588aab38b6c584d0f4519521066f96928ddaddd6bf34b3805f5343d4421a8cf9c7104636a9fed47274807",
      "line": 87,
      "relation": "increases",
      "source": 66,
      "target": 84
    },
    {
      "annotations": {
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "Knockout studies in mice suggest OGA plays a critical role in brain development",
      "key": "301c201c7d2de3be1696a616a78825c807111e234b3b8af8351838208bc2fa5a5ba58ce2030dea5f9458d44b7092ff24254545b54fc0a2e314f762605e093ebe",
      "line": 107,
      "relation": "association",
      "source": 66,
      "target": 25
    },
    {
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "Furthermore, downregulation of OGT leads to increased tau phosphorylation and onset of AD pathology.",
      "key": "f1c9ff22b60f2fff00a34b172974ee373ad86c80b0492219082bdbe02dc8e889c77b8825f44217da14ef81a32f622fc34ceaf098831f7be09b8191c740190135",
      "line": 343,
      "relation": "decreases",
      "source": 66,
      "subject": {
        "modifier": "Activity"
      },
      "target": 60
    },
    {
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "Thiamet-G was able to decrease effectively aggregation in tau-BiFC cells, even after treatment with BZX2, an OGT inhibitor reported to downregulate O-GlcNAcylation and promote phosphorylation and aggregation",
      "key": "c78120a880e8b94e55c5b43bf19ceb204a81d707875b299203b5b0333891b6245f85080459c6ba76513bb63e18a368dc97687381fabfde4157c92b2f3b5f1be2",
      "line": 408,
      "relation": "decreases",
      "source": 66,
      "subject": {
        "modifier": "Activity"
      },
      "target": 60
    },
    {
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "Furthermore, downregulation of OGT leads to increased tau phosphorylation and onset of AD pathology.",
      "key": "0f6bf062bd9b174b8c97f0fd282bfb250ea12e1d0c41e82a802741be5fbc976276b761c0bb2a2aadeca6a223bcf96bc3d8c7459a80199737c122efeec38aebbc",
      "line": 344,
      "relation": "negativeCorrelation",
      "source": 66,
      "subject": {
        "modifier": "Activity"
      },
      "target": 106
    },
    {
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "Thiamet-G was able to decrease effectively aggregation in tau-BiFC cells, even after treatment with BZX2, an OGT inhibitor reported to downregulate O-GlcNAcylation and promote phosphorylation and aggregation",
      "key": "c83aeadbf6bd356a31f9e1288cb9871a63f462ea283711c60a16b1c3810a6fef3ce0388c79ca742357ef2a5cfa153033ae3a9000d9cabae4baa5fe05510f3946",
      "line": 407,
      "relation": "increases",
      "source": 66,
      "subject": {
        "modifier": "Activity"
      },
      "target": 57
    },
    {
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "Thiamet-G was able to decrease effectively aggregation in tau-BiFC cells, even after treatment with BZX2, an OGT inhibitor reported to downregulate O-GlcNAcylation and promote phosphorylation and aggregation",
      "key": "1ec078a9e509051d1fa60c2da274f92d297e510ba6b39d37ef30339b1650d32fc1c95fa0405c754a765042ab573c9082fe83d9ec2b65757ddecfc9ce265f695a",
      "line": 409,
      "relation": "decreases",
      "source": 66,
      "subject": {
        "modifier": "Activity"
      },
      "target": 7
    },
    {
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "OGT-mediated transfer of O-GlcNAc onto proteins is therefore closely tied to cellular glucose concentrations, though notably glucosamine and GlcNAc may also be recycled via salvage pathways",
      "key": "a27f66eb9e751e5cafc9f70fbdda2875e5ad2ab828fe739b4f5b624f91f7bc34a3d186b89963085e38383c4253cde6c00ca05dc4ac37d1b8b84870dba9aadae0",
      "line": 88,
      "relation": "association",
      "source": 84,
      "target": 26
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Brain": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "In fact, it has been found that a decreased availability of glucose invokes a considerable reduction in the level of O-GlcNAc present in the mouse brain",
      "key": "0a986f79ec91a70d5f6e77cf8c03c31923395fafc69f28bb538dbd6ac798c8a706fb8b686b11e92fd3d45377b69654963a6aba0c9fec6b4d78bcc054df878e88",
      "line": 96,
      "relation": "positiveCorrelation",
      "source": 84,
      "target": 3
    },
    {
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "Furthermore, increased levels of O-GlcNAc via pharmacological OGA inhibition have frequently led to alterations in protein phosphorylation levels",
      "key": "c57549e5bba5deb23b0dd367ade342c9c8b2a2076364c4b9a8f50bec739d0e7fd5245f1bbd7d61c0113f45cdaeb5520e23513a52e1dd30b728e145656f4cc1b4",
      "line": 126,
      "object": {
        "modifier": "Activity"
      },
      "relation": "negativeCorrelation",
      "source": 84,
      "target": 65
    },
    {
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "Furthermore, increased levels of O-GlcNAc via pharmacological OGA inhibition have frequently led to alterations in protein phosphorylation levels",
      "key": "1f247bff5f0945c71494c30475e6aa04ddf7510508d7c40c0f142bba7ec3e58931e714c2667bf6620cbbeb34e99f18dd8c83a5a50fa2f74e74d45f4c9e2b33fc",
      "line": 127,
      "relation": "association",
      "source": 84,
      "target": 31
    },
    {
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "A proteomics study conducted by Hart and co-workers found that globally elevated OGlcNAcylation levels lowered phosphorylation at 280 sites while actually increasing it at 148 other sites",
      "key": "b898b401de595905d915c05386e402275f9a663f8b13c9ef3c772c9f9ed743bece1daffb632f128c64722e0c6afb226d44566acf174de592ddb4e8742f5f9a29",
      "line": 133,
      "relation": "association",
      "source": 84,
      "target": 31
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Brain": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "Gong and co-workers identified that impaired brain glucose metabolism actually leads to neurofibrillary degeneration via downregulation of O-GlcNAcylation.",
      "key": "18ef86827bbd06a2959b1f308b6fbbc098fd5757dfa62a16a883b8c154d04eba181b060178d7483cd752dac698452542d17d8d68ee27e974fe4ef424e5e647a5",
      "line": 360,
      "relation": "association",
      "source": 84,
      "target": 28
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Brain": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "Gong and co-workers identified that impaired brain glucose metabolism actually leads to neurofibrillary degeneration via downregulation of O-GlcNAcylation.",
      "key": "e11e6b24fe9e7fe7f39fbb9046ed94c9f2025ba29fb187a47b1dc5d0dc36ff16d5c91f6ba76cfe7ad2a38289a60733246dbc3852c00b175842bf2b4796f219e3",
      "line": 361,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "negativeCorrelation",
      "source": 84,
      "target": 14
    },
    {
      "key": "d2cd3023950229c1459145d792d22f8f1cc1bc889afbcd233b7a62e908427f7ee4af115a3d530572cc02c64096112d44349e5001dcaec3236ad8646a4df8809f",
      "relation": "hasVariant",
      "source": 83,
      "target": 84
    },
    {
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "The addition and removal of OGlcNAc onto protein substrates is governed entirely by two ubiquitously expressed enzymes: O-GlcNAc transferase [EC 2.4.1.255] (OGT) and O-GlcNAc hydrolase [EC 3.2.1.169] (OGA) respectively (see Figure 2).",
      "key": "59e1ec11a5bc60f3547ff72db856a9e5b48e8439b3d354c99e2c77bf8ebf971924db8f0c5e01ff22ac0c7cfedc04a85763bf2c49a2555aa18a4dcaf8db6ab377",
      "line": 82,
      "relation": "increases",
      "source": 65,
      "target": 84
    },
    {
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "Furthermore, increased levels of O-GlcNAc via pharmacological OGA inhibition have frequently led to alterations in protein phosphorylation levels",
      "key": "145c2f3d734b806d678633d9109c026a87be6fe911d57d350f95552d272a44a429001c36a2e49f01f06eb938d85af9340ede42b939f85468640ac8f4d0bfa071",
      "line": 126,
      "relation": "negativeCorrelation",
      "source": 65,
      "subject": {
        "modifier": "Activity"
      },
      "target": 84
    },
    {
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "Zhang and co-workers found that OGA inhibition via acute Thiamet-G treatment promoted phosphorylation of mTOR and AKT, leading to decreased autophagic flux and subsequent accretion of dysfunctional ASyn",
      "key": "9f6c489c47132a36e4847eb2292e4bb39b5a519a5b6e8219372d4b7ef9966f6e405abd67a0442532c0216a1e5d85569d7828dbd8f40ff1d59bf6a9e11df656d2",
      "line": 275,
      "relation": "decreases",
      "source": 65,
      "subject": {
        "modifier": "Activity"
      },
      "target": 64
    },
    {
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "Zhang and co-workers found that OGA inhibition via acute Thiamet-G treatment promoted phosphorylation of mTOR and AKT, leading to decreased autophagic flux and subsequent accretion of dysfunctional ASyn",
      "key": "6ae8f1342fa0548ba52dc75a0cf3a55a52d709a85cf9cd536e49d2a7ee4f7b22aee739ce09b529585dce80eb44fd87c4761b26d916381d6a4f0681d5d2cc86a4",
      "line": 277,
      "relation": "decreases",
      "source": 65,
      "subject": {
        "modifier": "Activity"
      },
      "target": 48
    },
    {
      "annotations": {
        "CellLine": {
          "Neuro-2a cell": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "Meanwhile, Vocadlo and co-workers reported that pharmacological inhibition of OGA, in each of neuroblastoma N2a cells, primary rat neurons, and a mouse brain, actually stimulates autophagy via an mTORindependent pathway",
      "key": "9ac71701623a9b73597a45d178d76fdc72cc1deb1a2553960ef3e15e85cd3240633cdd8125d80a9ca4a8c0f40187db69d16780014d4fc52226045a39755f37ad",
      "line": 298,
      "relation": "decreases",
      "source": 65,
      "subject": {
        "modifier": "Activity"
      },
      "target": 33
    },
    {
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "Inactivation of OGA dramatically promoted HD model toxicity while removal of OGT worked to alleviate toxicity",
      "key": "1e6d9815ee901d4a58071abb4e26cbe1952d10cdc8333de23afec9a19d2b37505f54d09c5328692e294a62d80998e49624ec026103ae87179a330623e4159e45",
      "line": 547,
      "relation": "decreases",
      "source": 65,
      "subject": {
        "modifier": "Activity"
      },
      "target": 55
    },
    {
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "OGT-mediated transfer of O-GlcNAc onto proteins is therefore closely tied to cellular glucose concentrations, though notably glucosamine and GlcNAc may also be recycled via salvage pathways",
      "key": "bf5c85301226673356945db62751299bbda7285bc2577df072f6e306adfcb1e795eeabdb89aadc621d06b9b18ad0565906d792f8a3003380c0f560937ee501b5",
      "line": 88,
      "relation": "association",
      "source": 26,
      "target": 84
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Brain": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "In fact, it has been found that a decreased availability of glucose invokes a considerable reduction in the level of O-GlcNAc present in the mouse brain",
      "key": "e31680d6fa65e2e50bf5a4ca7e3528030380f263c6dc52eb7294be6855118bfe92b56ce172c6909c72e1e7475aa8898bf5f8d953666200dbd34e4a4df73f8641",
      "line": 96,
      "relation": "positiveCorrelation",
      "source": 3,
      "target": 84
    },
    {
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "Furthermore, hyperglycaemic conditions yield increased levels of O-GlcNAc",
      "key": "5e76976b80cdc7df29877ff22d3a526d47e9b7d4f9d19b6e48ddaf6d1874400458f524c92ec611721e4f90fcd52950a34854ae1ca6df766d4a37c3606a56ccd3",
      "line": 102,
      "relation": "increases",
      "source": 111,
      "target": 84
    },
    {
      "annotations": {
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "Knockout studies in mice suggest OGA plays a critical role in brain development",
      "key": "12337a26abc09b348e6baccacd2d8ff27a97e25eceba477305fe19382f4428e42229fa156f1984e452494eea69a0c947475d6c5540934171893c82e36681148b",
      "line": 107,
      "relation": "association",
      "source": 25,
      "target": 66
    },
    {
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "Though highly potent, PUGNAc (1, Scheme 1) was found to also effectively inhibit human lysosomal hexosaminidase, limiting its utility",
      "key": "3e345a76c434bc5676286c91b3f944c64f4c33a8001e944b4716a55c6054e36f4da569c215a34b9c39db8e5b2e7e4d2fdaaf65ceb44498f05462028f006e58de",
      "line": 114,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 21,
      "target": 65
    },
    {
      "annotations": {
        "CellLine": {
          "SH-SY5Y": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "Treatment of SH-SY5Y neuroblastoma with PUGNAc, an OGA inhibitor, has increased levels of O-GlcNAc modified APP and secretion of sAPPÎ± while decreasing secretion of AÎ²40",
      "key": "e710e950aa17d7c8cb368ad554f2664bc792d07a4c47dd911885a7af740454afe26d3ece31b5d2a4acf16fa67a46c334186cf23be109203b5c8ce51cb656621a",
      "line": 473,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 21,
      "target": 65
    },
    {
      "annotations": {
        "CellStructure": {
          "Lysosomes": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "Though highly potent, PUGNAc (1, Scheme 1) was found to also effectively inhibit human lysosomal hexosaminidase, limiting its utility",
      "key": "7f0c2097cab964fbbf2f00b6e9713a9f015097fcaa2cf78499cbd22df2e0043081ec41638a0c04ceca29d59522db9ebeca4594f375ec9e40ac65486b2a3f3303",
      "line": 116,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 21,
      "target": 19
    },
    {
      "annotations": {
        "CellLine": {
          "SH-SY5Y": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "Treatment of SH-SY5Y neuroblastoma with PUGNAc, an OGA inhibitor, has increased levels of O-GlcNAc modified APP and secretion of sAPPÎ± while decreasing secretion of AÎ²40",
      "key": "fc3a7c4b96591854db215f476c5e8d898c26f0612ec3b8d5918a13aaae444c89aa0eb6282bff4ab4fa57f945648f40a4ca8e7ba796d0d3cec419b9d555c267fa",
      "line": 474,
      "relation": "increases",
      "source": 21,
      "target": 51
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Cell Membrane": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "Subsequent work indicated that O-GlcNAcylation of APP promotes its plasma membrane localization, facilitating its non-amyloidogenic processing",
      "key": "0490869b11e54d03d829b1ef616893fec3df98ff822802c28c2486764405559c1aa2985e7734d51689f2a46d18a1b92e1c76de2429bf64597feda5f85f3e6b24",
      "line": 501,
      "relation": "increases",
      "source": 21,
      "target": 51
    },
    {
      "annotations": {
        "CellLine": {
          "SH-SY5Y": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "Treatment of SH-SY5Y neuroblastoma with PUGNAc, an OGA inhibitor, has increased levels of O-GlcNAc modified APP and secretion of sAPPÎ± while decreasing secretion of AÎ²40",
      "key": "f3c477ef51943097579cc6ecd3daf05873d3b0192ba51a88e6573ba78310420c27beeadf865e4bdc8ba006a87d4c906ee3116fda6fdb2b836b4599b815681556",
      "line": 475,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 21,
      "target": 46
    },
    {
      "annotations": {
        "CellLine": {
          "SH-SY5Y": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "Treatment of SH-SY5Y neuroblastoma with PUGNAc, an OGA inhibitor, has increased levels of O-GlcNAc modified APP and secretion of sAPPÎ± while decreasing secretion of AÎ²40",
      "key": "cce1ee80fa8088b701fb8cc35e54a1a5faec538d7a4fbe69a36937839edefd16a667072a1f87d5c58e9426c05edf1df04ee918dd204b0aab86f509d39f5ae062",
      "line": 476,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "decreases",
      "source": 21,
      "target": 0
    },
    {
      "annotations": {
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "PUGNAc treatment increased the rate of APP trafficking to the plasma membrane from the trans- Golgi network and decreased the rate of APP endocytosis",
      "key": "0cc665f559741441d113f58071b5b0deb6e5d63134d020e351d8601c7b732d1e9c74da02e8e9a1bd161fe94432afe69f515ec6ea56b95187af3aaeb7b1900551",
      "line": 494,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "trans-Golgi network",
            "namespace": "GO"
          },
          "toLoc": {
            "name": "plasma membrane",
            "namespace": "GO"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 21,
      "target": 49
    },
    {
      "annotations": {
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "PUGNAc treatment increased the rate of APP trafficking to the plasma membrane from the trans- Golgi network and decreased the rate of APP endocytosis",
      "key": "62f8d30d36e050bd9f677c8c38b2724d578f2efcf0177dbd5a976faf80faaddd5b0eeb1ef9999f11ca819a551bf38de7e6442bbc97a5ae09b3cef97e46f5ef69",
      "line": 495,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "extracellular region",
            "namespace": "GO"
          },
          "toLoc": {
            "name": "intracellular",
            "namespace": "GO"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "decreases",
      "source": 21,
      "target": 49
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Cell Membrane": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "Subsequent work indicated that O-GlcNAcylation of APP promotes its plasma membrane localization, facilitating its non-amyloidogenic processing",
      "key": "e9899fe5eb10d91166589e21920d3b1eebd1073dd0131e76476c614bf30ab3f4428439e2930845165b7bf2dbd25bd9b5ba2587a09946a85a323c39ce7b0d2f85",
      "line": 502,
      "relation": "increases",
      "source": 21,
      "target": 22
    },
    {
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "Thiamet-G is able to permeate the blood-brain barrier and is highly selective for human OGA",
      "key": "81018cf9f61725947249f6040ff9a974d99b58c18f46cb953bf71398ed7967dd42d7b67ea926e3b6a4717d3ffc256d80e5e256be4e676143a335f06eb342f99b",
      "line": 121,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 20,
      "target": 65
    },
    {
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "Zhang and co-workers found that OGA inhibition via acute Thiamet-G treatment promoted phosphorylation of mTOR and AKT, leading to decreased autophagic flux and subsequent accretion of dysfunctional ASyn",
      "key": "9092bafe5a0a79c422a8770e1320c82010ca900cd520c78b678e6dbb8954a679d2c9b824b1a34a0d317727840446d32bdb6257ef9ad2205abc95f51cc205dcce",
      "line": 274,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 20,
      "target": 65
    },
    {
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "Thiamet-G treatment increased levels of monomeric ASyn after 7 days by 50% relative to the control.",
      "key": "4ef848b5f05d1d89a4ce93589d1a1de65fadb7bf0e4e9c7cf7aa51d76e65f8b50f1c0a25b89eb5eb4fc9f9bcece3a45af1d69adc09cb56323e61182d5fc2cf90",
      "line": 284,
      "relation": "increases",
      "source": 20,
      "target": 67
    },
    {
      "annotations": {
        "CellLine": {
          "PC-12 cell": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "Acute treatment with Thiamet-G effectively decreased phosphorylation of tau at pathologically relevant sites, Thr231 and Ser396, in PC-12 cells",
      "key": "480fca1d2a97c43a0c5218994dca4e555c9914033bc37d04a34ee0bfdd19d0f42b15790db2bd166b4d3948c5e046bbc6c3bd3296d316464dd038c83c110428dd",
      "line": 397,
      "relation": "decreases",
      "source": 20,
      "target": 62
    },
    {
      "annotations": {
        "CellLine": {
          "PC-12 cell": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "Acute treatment with Thiamet-G effectively decreased phosphorylation of tau at pathologically relevant sites, Thr231 and Ser396, in PC-12 cells",
      "key": "eae1d9b8b1692de203ffed8adf062c949ba675885a69daf42459ab162649eb8ae698e40c76e492f44f7c79aa61f8ca7bfea83ff6ff03928fcfbc12ccf0a9d6f1",
      "line": 398,
      "relation": "decreases",
      "source": 20,
      "target": 61
    },
    {
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "Thiamet-G was able to decrease effectively aggregation in tau-BiFC cells, even after treatment with BZX2, an OGT inhibitor reported to downregulate O-GlcNAcylation and promote phosphorylation and aggregation",
      "key": "b52f2b487a4486a37b3f3f4379fce384e12d13bc8abd6ac4a6b1137d3d57f3ad015462b231d361acbb6c03b1d73647ae750e75b9d0347763e00260fda323c6c3",
      "line": 406,
      "relation": "decreases",
      "source": 20,
      "target": 7
    },
    {
      "annotations": {
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "Long-term treatment of JNPL3 tau tg mice with Thiamet- G increased levels of O-GlcNAc modified tau while decreasing levels of tau aggregates and neuron death",
      "key": "dbc35e57c00cd3a4b0b938f4537f0aba7f60eb1756a210a445af5f3d38a6c7f17b3dca99a2507eb4d5b3529879a1276250ef00779f9e1fe0b49d99b861f7c0de",
      "line": 429,
      "relation": "decreases",
      "source": 20,
      "target": 7
    },
    {
      "annotations": {
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "In rTg4510 mice, acute treatment led to increased tau O-GlcNAcylation, reduced tau phosphorylation at epitopes S202/S205, S626, S356 and S396 (notably excluding S400), besides reducing levels of pathological tau aggregation",
      "key": "43e7e489e763a68d18d047782b47907ca91298a34f9b37344dac655b76772ae39610a30b310d6176307a2a0f57f7f5e0ccf001ded75689100d5463083efbf158",
      "line": 447,
      "relation": "decreases",
      "source": 20,
      "target": 7
    },
    {
      "annotations": {
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "Subsequent studies on rTg4510 mice found their chronic treatment reduced pathological tau in the brain besides total tau in the CSF also.",
      "key": "bf414a1b70c9026b80b4537c892bfeac73066e2f77758dd714f00a20f9389aa2610d48c03076b84d7c754440b67611759e24fedf9db1f9d80d34ee91b8693ea6",
      "line": 456,
      "object": {
        "location": {
          "name": "Brain",
          "namespace": "MESH"
        }
      },
      "relation": "decreases",
      "source": 20,
      "target": 7
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Cerebral Cortex": true,
          "Hippocampus": true
        },
        "Species": {
          "10116": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "Thiamet-G remains effective in vivo, efficiently reducing phosphorylation at Thr231, Ser396 and Ser422 in both rat cortex and hippocampus.",
      "key": "afde99ce1882915c928c260286ac08d1ed9152a74cff00ab01fb97a80aad897abc5a51712b7dd44adf2d4e9a09dda170235148101e8614aecda8a54927cd9673",
      "line": 417,
      "relation": "decreases",
      "source": 20,
      "target": 103
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Cerebral Cortex": true,
          "Hippocampus": true
        },
        "Species": {
          "10116": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "Thiamet-G remains effective in vivo, efficiently reducing phosphorylation at Thr231, Ser396 and Ser422 in both rat cortex and hippocampus.",
      "key": "53c9b270db126676fbc901eaf4c4ebb0a81ba207f67226371fd3af28722a2c96aeace93c2bff88d7ec825d46479a0f4d856cef82c0ba904c7d30840caa4a9ccd",
      "line": 418,
      "relation": "decreases",
      "source": 20,
      "target": 101
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Cerebral Cortex": true,
          "Hippocampus": true
        },
        "Species": {
          "10116": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "Thiamet-G remains effective in vivo, efficiently reducing phosphorylation at Thr231, Ser396 and Ser422 in both rat cortex and hippocampus.",
      "key": "8a969169c7120bdc4218c5e46e71caa4b3f03360632aa2873fb9c405951443551b72a6b6492331c6694757320ee224e00a83dfed8e5dae60267acfafd0aa91d5",
      "line": 419,
      "relation": "decreases",
      "source": 20,
      "target": 102
    },
    {
      "annotations": {
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "Long-term treatment of JNPL3 tau tg mice with Thiamet- G increased levels of O-GlcNAc modified tau while decreasing levels of tau aggregates and neuron death",
      "key": "a474068d45447b9b69245af4de8e15f0cd1e648b617aadcda51787026429ff3056881bf30513e32fdba204113b557c057c1ccda69ed571c84881d41d859a2ef6",
      "line": 428,
      "relation": "increases",
      "source": 20,
      "target": 86
    },
    {
      "annotations": {
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "In rTg4510 mice, acute treatment led to increased tau O-GlcNAcylation, reduced tau phosphorylation at epitopes S202/S205, S626, S356 and S396 (notably excluding S400), besides reducing levels of pathological tau aggregation",
      "key": "5bc57c2ab7ccce15e3862fb5e116352e70042c9ce1640f85996a888e9434f7de071a80bf59336939e744f3a9536698a4fd7fdfa20934099ee507c306c85c2721",
      "line": 441,
      "relation": "increases",
      "source": 20,
      "target": 86
    },
    {
      "annotations": {
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "Long-term treatment of JNPL3 tau tg mice with Thiamet- G increased levels of O-GlcNAc modified tau while decreasing levels of tau aggregates and neuron death",
      "key": "5df0d804875c35d5108941d68d604a71741bcf4046b3de98c4ca4ecd279e7fee0c9dd1cda7818b12e6a6d6b24c2160edb61f4fc4115d2493f08947f0f61de33f",
      "line": 430,
      "relation": "decreases",
      "source": 20,
      "target": 30
    },
    {
      "annotations": {
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "In rTg4510 mice, acute treatment led to increased tau O-GlcNAcylation, reduced tau phosphorylation at epitopes S202/S205, S626, S356 and S396 (notably excluding S400), besides reducing levels of pathological tau aggregation",
      "key": "938d2c9158a390960926309a48486b2ba5329f5b139b85d5eca48f34f1e1f4ba4c8c09dc096c314fc13358df8f22950b403ac128e64c761f4cd807702527fb98",
      "line": 442,
      "relation": "decreases",
      "source": 20,
      "target": 89
    },
    {
      "annotations": {
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "In rTg4510 mice, acute treatment led to increased tau O-GlcNAcylation, reduced tau phosphorylation at epitopes S202/S205, S626, S356 and S396 (notably excluding S400), besides reducing levels of pathological tau aggregation",
      "key": "70190503ed7825946eeeb662fa4e0df7cd99a30bb96f3f9ec87cce2b2a322bdb56a7314d22971ac40bcf9bea29d605a3b084d16fb5aaa423808633a558f56059",
      "line": 443,
      "relation": "decreases",
      "source": 20,
      "target": 93
    },
    {
      "annotations": {
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "In rTg4510 mice, acute treatment led to increased tau O-GlcNAcylation, reduced tau phosphorylation at epitopes S202/S205, S626, S356 and S396 (notably excluding S400), besides reducing levels of pathological tau aggregation",
      "key": "2f6b023709f463bced173142ed6befe45d2e9e2cda949dbd92330e1bd52fac30f358e4531888217b73910a171a52a58b7a31c214cfd5c4eb3a820a453151cf2a",
      "line": 444,
      "relation": "decreases",
      "source": 20,
      "target": 90
    },
    {
      "annotations": {
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "In rTg4510 mice, acute treatment led to increased tau O-GlcNAcylation, reduced tau phosphorylation at epitopes S202/S205, S626, S356 and S396 (notably excluding S400), besides reducing levels of pathological tau aggregation",
      "key": "3c5a365e338050e4efa39b05d9fa1643ad8a072f249f908b8ba214549ff569a72a376f3b40d6bf389a1b7e96a58271523184a8892602c055dc7250b85591d9c6",
      "line": 445,
      "relation": "decreases",
      "source": 20,
      "target": 91
    },
    {
      "annotations": {
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "In rTg4510 mice, acute treatment led to increased tau O-GlcNAcylation, reduced tau phosphorylation at epitopes S202/S205, S626, S356 and S396 (notably excluding S400), besides reducing levels of pathological tau aggregation",
      "key": "253031f98e7385e74b41aee2433ee786268ec25c75133a8606413cce56e51e545e9d49e021226670fbc6c9de79a7b6ef6fb2a02f4a30493edce5df2e78d5393c",
      "line": 446,
      "relation": "causesNoChange",
      "source": 20,
      "target": 92
    },
    {
      "annotations": {
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "Subsequent studies on rTg4510 mice found their chronic treatment reduced pathological tau in the brain besides total tau in the CSF also.",
      "key": "4830c20e85b0c24359e25cdea9b5e8be8746ea425a29445a970179922ec809a4fa5d988eba5fff29ac99e8174a46e40328b6d03e065742cc335c968805c8d82a",
      "line": 457,
      "object": {
        "location": {
          "name": "Cerebrospinal Fluid",
          "namespace": "MESH"
        }
      },
      "relation": "decreases",
      "source": 20,
      "target": 56
    },
    {
      "annotations": {
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "Thiamet-G treatment of tg TAPP (tau/APP) mice blocked cognitive decline paralleling decreased AÎ² and plaque levels while not affecting tau phosphorylation",
      "key": "e06a173bd3f5bda76d844c9084d3796a9ae20aa56874a01e0ec84e83589c578eecd43cddaa1f4134fa3836782f5f5fc8e7a6c6ec533d1639d9d1fade290c87a5",
      "line": 510,
      "relation": "increases",
      "source": 20,
      "target": 34
    },
    {
      "annotations": {
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "Thiamet-G treatment of tg TAPP (tau/APP) mice blocked cognitive decline paralleling decreased AÎ² and plaque levels while not affecting tau phosphorylation",
      "key": "32146a1e3fd2b902f8708fa4470c955f0e7824bcd9484d72cb57d017e6867cb688f09cb690cdbd823d7888e6a4f7a09262b8816d02b2eb9ddf14356fdbab755f",
      "line": 511,
      "relation": "decreases",
      "source": 20,
      "target": 1
    },
    {
      "annotations": {
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "Thiamet-G treatment of tg TAPP (tau/APP) mice blocked cognitive decline paralleling decreased AÎ² and plaque levels while not affecting tau phosphorylation",
      "key": "08bfa24ab11a2c27aa7212cf586d01d03de006ff223961dbdd1833506d1e01e7bb88736472f126c7bbe4a08d2661dd00b78d7fae21e7fef7eb0e31c030c9b146",
      "line": 513,
      "relation": "causesNoChange",
      "source": 20,
      "target": 88
    },
    {
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "Furthermore, increased levels of O-GlcNAc via pharmacological OGA inhibition have frequently led to alterations in protein phosphorylation levels",
      "key": "07e1cb1551ef2c93f44af5bbb7af8266a9f51b71df9776cfc84cef67fc7fea304bcf53bcfaf53b1c0846b49f37e27d4c89c7fb170743dfcc714373ef5549933f",
      "line": 127,
      "relation": "association",
      "source": 31,
      "target": 84
    },
    {
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "A proteomics study conducted by Hart and co-workers found that globally elevated OGlcNAcylation levels lowered phosphorylation at 280 sites while actually increasing it at 148 other sites",
      "key": "6c2e1ce5d13cb193aac4ec11c5641ac6b87f445e7502c38510097c19c45ae7a6b37f18e80a46349eac5a55cc4d485d59f457c60b056f98871cee975f20175de9",
      "line": 133,
      "relation": "association",
      "source": 31,
      "target": 84
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Substantia Nigra": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "PD is characterised by the progressive degeneration of dopamine-producing neurons in the substantia nigra, resulting in impaired motor function",
      "key": "1804e66f88aad3dceb7b365f348da516620704de4c6781ed6f41dc14db3ac1e934f4eabd170c6cafec46d6630e3d8dd00c61feb40e5318dc6d764fed2016d38d",
      "line": 140,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "positiveCorrelation",
      "source": 109,
      "target": 6
    },
    {
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "The current consensus is that ASyn self-assembly plays a critical role in PD, whether it be a cause or symptom of the complex pathological cascade.",
      "key": "c690ab8d0f10665fd1102a3ef96697d46375e7a46956057a271e27ea63c8d672a72809ae742c6edcb85980346b538b02d30c9af413f084a1f39f9e3a95f650a0",
      "line": 159,
      "relation": "association",
      "source": 109,
      "target": 38
    },
    {
      "annotations": {
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "Calpain activity correlates with disease progression in PD mouse models",
      "key": "100bdb8c64d16a2c4753cf0195c9cfe31b498c843e4934ce2071bfc2c40f7d257527f3a2d4a26e254dcbd8f59978b553d956d3d42b9a13bb66009fb55759b121",
      "line": 201,
      "object": {
        "modifier": "Activity"
      },
      "relation": "association",
      "source": 109,
      "target": 82
    },
    {
      "annotations": {
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "As mentioned previously, calpain activity correlates well with disease progression in PD mouse models, catalysing the truncation of ASyn into aggregation-prone species",
      "key": "2386d21080f93c7c0ae8ab113bd7863ad688703f5b6df98875095513a1f04663a941ec9503251cb01327e461afb63ab786d43c3d03d9e8b87e035d0b9ccc2cd7",
      "line": 250,
      "object": {
        "modifier": "Activity"
      },
      "relation": "association",
      "source": 109,
      "target": 82
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Substantia Nigra": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "PD is characterised by the progressive degeneration of dopamine-producing neurons in the substantia nigra, resulting in impaired motor function",
      "key": "757a5716f241849f7b2f512bef98beb3fa128465c32b91be56ea1e104395530a7a3fff8d931b9316b0a9a8df4d3b525f6ed9b7b2f74613712a2352cb988d416b",
      "line": 140,
      "relation": "positiveCorrelation",
      "source": 6,
      "subject": {
        "modifier": "Degradation"
      },
      "target": 109
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Substantia Nigra": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "PD is characterised by the progressive degeneration of dopamine-producing neurons in the substantia nigra, resulting in impaired motor function",
      "key": "e6059471c7a20fdf1cebe2d29d4becb721908ac6e291806cc22f4f9a8715dbc1696a560a965cac242ad6064872877b8f0936d4320ef7ab8be48b4ae80b50da70",
      "line": 141,
      "relation": "negativeCorrelation",
      "source": 6,
      "subject": {
        "modifier": "Degradation"
      },
      "target": 29
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Substantia Nigra": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "PD is characterised by the progressive degeneration of dopamine-producing neurons in the substantia nigra, resulting in impaired motor function",
      "key": "29f911711137efc8e34a1743051415d24ec72265406178056fcc63227a60f3898e4d994310d728583779d52d6593cff9b288f4dc7cb0ce81bde9a7aecacd057d",
      "line": 141,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "negativeCorrelation",
      "source": 29,
      "target": 6
    },
    {
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "This impairment manifests compromised postural reflexes, muscular rigidity and bradykinesia in patients.",
      "key": "4c09077f353b8e713490bfc41b0c20114b6b1cbe65339549642141edc64de2a52e1a17aeaca864fa9392fa34f106d2b825e9e8999f6a761dd61adbd79430ae1c",
      "line": 147,
      "relation": "decreases",
      "source": 29,
      "target": 112
    },
    {
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "This impairment manifests compromised postural reflexes, muscular rigidity and bradykinesia in patients.",
      "key": "0dde41f712d9bbec967e26392d7fd7132292773a9a31dc552cc6d00b46963d2d5d97911a7573fc769b0c6e8d98fa38b488449637bb4ff3f137fe7185ef91285a",
      "line": 148,
      "relation": "decreases",
      "source": 29,
      "target": 108
    },
    {
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "This impairment manifests compromised postural reflexes, muscular rigidity and bradykinesia in patients.",
      "key": "6cc08c773fd7877daafcdf6e87e12efa30207ed82f37e1e4f58bd1f8714710c7305802072f1aaae4be4c8dfb5f79e4f744504c95e53b7b8e468d065d61a61b32",
      "line": 149,
      "relation": "decreases",
      "source": 29,
      "target": 105
    },
    {
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "Point mutations in the ASyn gene (SNCA) underlie familial disorders with parkinsonian characteristics, suggesting a pathogenic role for ASyn accumulation",
      "key": "9d50359b5214a73c9d64761d43cb21fa0526e76f297d29adea4e3e6e2472f5e2de6c7f50b6a61f9fdb2114520bd59cadb32aa6bc682a899af162e0b86ff140a9",
      "line": 154,
      "relation": "increases",
      "source": 78,
      "target": 109
    },
    {
      "key": "892d371737b8a859289caced4c4d763309650497f2e73b58bc379b64d1f7a3a19962c0ee817a361a6bbbcfb96d11c59e50167d5baa9b2fe04a181b6576d47322",
      "relation": "hasVariant",
      "source": 67,
      "target": 78
    },
    {
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "Reports suggest ASyn has a role in regulating supply and management of synaptic vesicles,57 while also possibly regulating neuronal release of dopamine, a neurotransmitter involved in controlling voluntary and involuntary movement",
      "key": "b112b1ea1c98fb93f150f79bdbb80cbe9be5a86bb2a7ee50074cd92a45379114b3ed415da438df807f89cf389d98d4b4ac595c1f0961e4590ca218b2fcb1ae84",
      "line": 166,
      "relation": "regulates",
      "source": 67,
      "target": 15
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Neurons": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "Reports suggest ASyn has a role in regulating supply and management of synaptic vesicles,57 while also possibly regulating neuronal release of dopamine, a neurotransmitter involved in controlling voluntary and involuntary movement",
      "key": "dad6e754e6ef3975ef8a3447fd349b2d832e0adce5029b54dce06979126e6ce9278bd0a85c31e9f150c75a65245ce89d2d99c9ea8f7cb767e35bad05fbec6c4c",
      "line": 168,
      "relation": "association",
      "source": 67,
      "target": 27
    },
    {
      "key": "9b9d016882948650eb2883dbad8a693caa9e70a871f23d733e1a0d8308e030a311dcbae352c6b6c01e7b21aa4616ad5f5b70dfe2a9aaeee39c88262c633fb385",
      "relation": "hasVariant",
      "source": 67,
      "target": 70
    },
    {
      "key": "8b33ffc00ae7c4456651a2f54c7d222899d0cce3ef452d990817774cf5ea992aa398bc0bf62f1ad8ae6704ff66ffc417aefeb74486233db9a2782aac366b9334",
      "relation": "hasVariant",
      "source": 67,
      "target": 69
    },
    {
      "key": "b138947b9495e4f055174d727a802ae3312df33fbff489895723ccaa760f81a08c22b1b0110928ffcde7882cea96e2aa5178ae48b8c9fae98bbb19e9825393d5",
      "relation": "hasVariant",
      "source": 67,
      "target": 77
    },
    {
      "key": "b6074ece2de9b917472d2d7e9883e9d2fa2c37c78d49bbdee95d20930c375d217f6be41121ebc283f78e08d3de6156638c08245ae28a5518c559e85a5e09fb5c",
      "relation": "hasVariant",
      "source": 67,
      "target": 71
    },
    {
      "key": "bfe684a9688fdf64e74b90b0fc2f2302cea431fee5a214293d1cb69cd813a856d71af43433f5cd8ae4ddc736cfb7df52d4daef9fbdea60d8d36818cbd642dca9",
      "relation": "hasVariant",
      "source": 67,
      "target": 74
    },
    {
      "key": "515a16ae68fad5f263cc3ea1f2ba224581cb96a7e015b2cac3431a53593aa00481e54ca0fb6e8780f173d4246b82c7cce9f13c215c47a8ba31b25566ca825d53",
      "relation": "hasVariant",
      "source": 67,
      "target": 72
    },
    {
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "TEM found semisynthetic ASyngS87 forms shorter fibrils than the wildtype, while ASyngT72 formed only small, broken fibrils",
      "key": "36407664c1d2b406a104bae362a1abefbfb18316206e50a9e38fcbe3270c8039098c243a716f17188a7421a9ce2af9196d90215447b878ecfc3f9828a9930fbd",
      "line": 231,
      "relation": "increases",
      "source": 67,
      "target": 11
    },
    {
      "key": "5fc836913559b65a0b48c12c16ba38886f8fab6571fa6477aac0c35212d3721058a6cccf4da3080d66037e53f9f947160ff9f5456e712d01cd5eaad928281f95",
      "relation": "hasVariant",
      "source": 67,
      "target": 75
    },
    {
      "key": "be2e037d6927c68d044f5e69db39ffd9f9f7941e00cde5da22bc6e9075d7b7a6eaea1a8be64ad1b3df59b3290c33f182001caaf0c6b03b73e1a67f91ba3647e7",
      "relation": "hasVariant",
      "source": 67,
      "target": 76
    },
    {
      "key": "59d10d711978c2a2bedf3f12274a95e0fac593048bfc685ca99716e2b3f92647e75a3ca77b18c7d5d7402c1783f5c4fa3eb2f66e85040691f9284371e8dfb8c6",
      "relation": "hasVariant",
      "source": 67,
      "target": 73
    },
    {
      "key": "22661154caef74f527310973d855a3dff1745e1b9aa181e6c4d0cd876b2e7281b61279004c09a5eff25efe1457eea06a78116bd9c98a89293bf666891a1727cf",
      "relation": "hasVariant",
      "source": 67,
      "target": 68
    },
    {
      "key": "d70240cbd86587b1d77e94b4af342845f9e1fb3efebdc94809a915c371fd82106b44dbc9f7941c5b843b20c09d9ea81a0330a6c4cde0d2a991ad2fc2c2fcb08c",
      "relation": "hasComponent",
      "source": 38,
      "target": 67
    },
    {
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "The current consensus is that ASyn self-assembly plays a critical role in PD, whether it be a cause or symptom of the complex pathological cascade.",
      "key": "9a76d2828532ccbd71e5eca94257c321933b3f7e1fddbe3f915fb401a4e8d41a4d06e1f4a4ed65732012db6011c623dcee30a48011797503d6adea308a60c84f",
      "line": 159,
      "relation": "association",
      "source": 38,
      "target": 109
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Neurons": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "Reports suggest ASyn has a role in regulating supply and management of synaptic vesicles,57 while also possibly regulating neuronal release of dopamine, a neurotransmitter involved in controlling voluntary and involuntary movement",
      "key": "791c40a501599d6428b90257789830eb1f5a3fb1d3d18170a39dfa31dc280a848c0ee87772be162ec33acf4ea4cfd7ae43385c7899cac255e677a790ce9822d0",
      "line": 168,
      "relation": "association",
      "source": 27,
      "target": 67
    },
    {
      "key": "fdfc6389408dcbded58ce55eed572a6c9de5deb4ccb954dcda938b1ee0239f05e128859c33b65f028085d421d701087f505dccd0ac2014604992c26e4545d2db",
      "relation": "hasComponent",
      "source": 35,
      "target": 4
    },
    {
      "key": "ed83008f91b00270d380e00e1d685ddddcdd3109c830cacabe2a8d414e8fe5b0bd522ce64efedea8c13baa3fa2a2a0001427a529a4ab2db2f357fb7db2dfee62",
      "relation": "hasComponent",
      "source": 35,
      "target": 67
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Cell Membrane": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "ASyn binds simultaneously to plasma membrane phospholipids (via its N-terminal domain) and to synaptobrevin-2 (via its Cterminal domain) to promote SNARE-complex assembly.",
      "key": "cf89852acbe4c26c5ff5032be994cf6207e6110e1b439fcfdb6247920666c8200d1a8959ea646293fdb9839dc50f5ec5f89099ba0f12b57995cf310e109b6629",
      "line": 174,
      "relation": "increases",
      "source": 35,
      "target": 23
    },
    {
      "key": "c4cd67590c9334a284cad56c0b1c2b1d038077ca87d117370b474e3fb9845b0c7da668381b3b40c1296be17a46bb2b698cc1601b77fa6c3f0f0fa28b559a06e9",
      "relation": "hasComponent",
      "source": 39,
      "target": 67
    },
    {
      "key": "2c6a04c9b9dc2b8658eec0e223000885dc7df76214a4245968704db5a5e831bdbae0001cc2f71201257ffc9bfb5abf3f230ce899b674bdac0d6bba9bc37e32f2",
      "relation": "hasComponent",
      "source": 39,
      "target": 81
    },
    {
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "ASyn binds simultaneously to plasma membrane phospholipids (via its N-terminal domain) and to synaptobrevin-2 (via its Cterminal domain) to promote SNARE-complex assembly.",
      "key": "0a85ffb7677004c48aa2b698ecce6f23206c26bc121210c850525b156bce8a65feb6ef091ef08ae73c2ddf74769ff57fca093c7dc00603e4ce7516818b0bdf41",
      "line": 176,
      "relation": "increases",
      "source": 39,
      "target": 23
    },
    {
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "It has been suggested that large ASyn aggregates actually work to sequester other harmful conformers, thus acting in a neuroprotective manner.",
      "key": "2370bbe2342497c852a2106177221058f2d1326fd27ef7bdea1ce57923a7b654d5d74c7154537d46c34026f98462b8093e1ebfd112593d13b755593953dd08f6",
      "line": 180,
      "relation": "decreases",
      "source": 10,
      "target": 30
    },
    {
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "The authors suggested that OGlcNAcylation as studied in their case, had promoted oligomer-formation underlying the reduced aggregation",
      "key": "22b5aa49e99f031c3a70118bfc57f20579835a36a7697cf92757c048b778acbb66a397d48fa330a9ea7c7492fd90a94418b38b6cab47a3a84680ef8bad9ead1e",
      "line": 268,
      "relation": "negativeCorrelation",
      "source": 10,
      "target": 12
    },
    {
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "Notably, cleavages at the ASyn C-terminus typically increase the resultant truncated proteinâs aggregation, as has been demonstrated in vitro and in overexpression experiments",
      "key": "d6637af2fa8898ee4201f09734e90320066db1625572fa904558682d29151287018800997e7064a58942b59c9e896a1361d9cfc549d340b02458620e0d100e19",
      "line": 186,
      "relation": "increases",
      "source": 70,
      "target": 10
    },
    {
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "Specifically calpain, a cysteine protease, cleaves soluble ASyn at a number of sites.",
      "key": "9a51906f6c838413e203aebcee0639dc9ece6ee298bee2fa51175b55185c58621b58eb6c5d55263f5d024faf4a52a1e5f431c406f646d2fdd0f4a03e9332fbaf",
      "line": 191,
      "relation": "increases",
      "source": 82,
      "target": 69
    },
    {
      "annotations": {
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "As mentioned previously, calpain activity correlates well with disease progression in PD mouse models, catalysing the truncation of ASyn into aggregation-prone species",
      "key": "b3e29f89202bb106a522768af71f0f39ab5e811bcbdd4d4f77484e46afcd33dc4fd809798ca0704df03a1af87386b2d6a84f93b1a612f304872a59b3e56300ff",
      "line": 251,
      "relation": "increases",
      "source": 82,
      "subject": {
        "modifier": "Activity"
      },
      "target": 69
    },
    {
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "Calpain also cleaves ASyn fibres to generate C-truncated forms which promote seeded aggregation",
      "key": "00116ecea846f98d0c1fef73813a548bbf7ba3386ad79b1613bab9340bb120ae2501464f6ca511b93243aecb21d11ebd88084461cf4b50a39034e3682afd3aea",
      "line": 195,
      "relation": "increases",
      "source": 82,
      "target": 45
    },
    {
      "annotations": {
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "Calpain activity correlates with disease progression in PD mouse models",
      "key": "1b20473f2742aef6e6422ced86b38ef63e593f425cb3efb906cf9b2d2442015985e541144aaf8b740f59863ea6ec2a25924e17c58799162286ea3278b3962f61",
      "line": 201,
      "relation": "association",
      "source": 82,
      "subject": {
        "modifier": "Activity"
      },
      "target": 109
    },
    {
      "annotations": {
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "As mentioned previously, calpain activity correlates well with disease progression in PD mouse models, catalysing the truncation of ASyn into aggregation-prone species",
      "key": "690651bca9db7a856a25cd9ca92c8329896aed23c8117aebf801f3b774c85dfba6fd04cd663c48def01fa939fd0c4f4f01b3a0ba93a3f1d35287ca7cb2c15927",
      "line": 250,
      "relation": "association",
      "source": 82,
      "subject": {
        "modifier": "Activity"
      },
      "target": 109
    },
    {
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "Both the synthetic ASyngT72 and ASyngS87 peptides exhibit strong resistances to cleavage from recombinant calpain, where unmodified ASyn is degraded rapidly",
      "key": "b7e85681f13c32d177022a864e16d102634a281b0c120e715bc471073c119e68190dc133d6ef9db5824c0bc1ffb50e46e3fa79944a73d5507b0042735095d5ee",
      "line": 259,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "causesNoChange",
      "source": 82,
      "target": 74
    },
    {
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "Both the synthetic ASyngT72 and ASyngS87 peptides exhibit strong resistances to cleavage from recombinant calpain, where unmodified ASyn is degraded rapidly",
      "key": "7782c5d44a8ef01f1b0be6251063c4274fa4a25977808b1de4ef876083afb2a3866e7fd0b11d2a008faa2613f5a210564f0b4e101bab3c5dce99b9cb12e1a795",
      "line": 260,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "causesNoChange",
      "source": 82,
      "target": 72
    },
    {
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "Both the synthetic ASyngT72 and ASyngS87 peptides exhibit strong resistances to cleavage from recombinant calpain, where unmodified ASyn is degraded rapidly",
      "key": "2c6efa50a9e6d2689ee23b68d675b2e6607711a116b245d577c4f813ea4e918556e61ca4a78427f76ddeeaddb9d175bf73409a870d51e6233649797bbce140f2",
      "line": 261,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "increases",
      "source": 82,
      "target": 67
    },
    {
      "annotations": {
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "As mentioned previously, calpain activity correlates well with disease progression in PD mouse models, catalysing the truncation of ASyn into aggregation-prone species",
      "key": "c6b79785f4d16040dcac88c55f305e045df5c558fc602b0a164e5c662afca06cce70b3f21173c7b051b1265b382d0cba65c8f9398e0646f6147950b5ed4c025f",
      "line": 252,
      "relation": "increases",
      "source": 69,
      "target": 10
    },
    {
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "Calpain also cleaves ASyn fibres to generate C-truncated forms which promote seeded aggregation",
      "key": "7dd66ff56754c7b3261193c7866d2e64c40be236e0212f44879538a8f01b1ba87b5e9191a79646076d75a3ff2989b85859f10ca803550b2859788035a4b99c26",
      "line": 196,
      "relation": "increases",
      "source": 45,
      "target": 10
    },
    {
      "key": "01be50fd6e62ba53f3846bf47e7130d8c0e66749228dfa43ba2f35eb1dbc41192b90046ca8cc34400825aeb529a0120dcf8b6099d40dafdc88de7b06aab735f4",
      "relation": "hasVariant",
      "source": 44,
      "target": 45
    },
    {
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "An estimated 90% of the proteins constituting ASyn aggregates bear phosphate groups at Ser129, suggesting that ASyn phosphorylation, or at least elevated levels of phosphorylated ASyn, contributes to PD pathogenesis",
      "key": "1f7690505647d9fea3aa0b61bbaf8b01a2be9034910a5aac8bd360fe3dfd50776dedaabca0a4c30b55ef0592c5c578e6107691cf66e1c3eb28d59fa73e9818eb",
      "line": 209,
      "relation": "increases",
      "source": 77,
      "target": 109
    },
    {
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "The O-GlcNAc modification has been shown to slow the aggregation rate of ASyn relative to the wild-type.",
      "key": "b65c66dfbd9d3a4cb09e8caf1b98155e04e39cb25111c309b86f76c3e3768adfc68f2a6505ff2a32784d9c6b7db4dbb7ecfd2367631fdc031c93a2f8dad1942c",
      "line": 214,
      "relation": "decreases",
      "source": 71,
      "target": 10
    },
    {
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "The authors suggested that OGlcNAcylation as studied in their case, had promoted oligomer-formation underlying the reduced aggregation",
      "key": "3b01942071a004738ed2aebe495880bb217b6d259cb0f6174fb51d9c25a4a1918ff5f581860d413088260af38ebf96192f5bf553c11c35d01e9abbaa5deade1e",
      "line": 267,
      "relation": "increases",
      "source": 71,
      "target": 12
    },
    {
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "Initially it was found that semisynthetic ASyn bearing an O-GlcNAc unit at Thr72 (ASyngT72) displayed a reduced self-assembling propensity relative to the wild-type during thioflavin T (ThT) fluorescence assay",
      "key": "a7ae453d503f14d2434459cc1a2c71e87f34edcc0ffe9dda7d4078e04ffef97199698371f41cb2063f75deaab675f12c78c2b43ce13459a3780386fe118c204b",
      "line": 221,
      "relation": "decreases",
      "source": 74,
      "target": 38
    },
    {
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "In fact, ASyngT72 did not form aggregates even after 7 days of incubation",
      "key": "aaeac87275c155069e655c0ffd932821f476d267c86b2b1518c1f1b9db0a92a15015e7779df91bed0909fb5418ac5667563c7947be33017b75c051002a432630",
      "line": 225,
      "relation": "decreases",
      "source": 74,
      "target": 10
    },
    {
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "TEM found semisynthetic ASyngS87 forms shorter fibrils than the wildtype, while ASyngT72 formed only small, broken fibrils",
      "key": "bd902791f8d683ae856e513ef1b54150e5c43bca6baa77c58e7645dcadd1d4ed483fa2dd26926aec839ab3c7f27dbc41577ca0cc9dea86f750c01da44e27b6e4",
      "line": 230,
      "relation": "increases",
      "source": 74,
      "target": 11
    },
    {
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "TEM found semisynthetic ASyngS87 forms shorter fibrils than the wildtype, while ASyngT72 formed only small, broken fibrils",
      "key": "09ef1b99724acf3ba3c51421021c1e2f4ebdff0e880994264811b5df5841112b1692eed712ae70d9d65dc76e598ff2a1d1492ef437e8f41893a2f96bceb21ce8",
      "line": 229,
      "relation": "increases",
      "source": 72,
      "target": 11
    },
    {
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "ASyngT75 and ASyngT81 formed rare, highly irregular aggregates, and the peptide tri-O-GlcNAcylated at all of Th72/Thr81/Ser87 did not aggregate at all.",
      "key": "3a90fb8520ab40a3c4811b8efde4a21938f0e85fad4f206bd921302222a947cdb2ed919df8c286cdf9b0cb3ea988d4dd3ee7500d7915bcc05acdca4f41736d76",
      "line": 236,
      "relation": "increases",
      "source": 75,
      "target": 10
    },
    {
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "ASyngT75 and ASyngT81 formed rare, highly irregular aggregates, and the peptide tri-O-GlcNAcylated at all of Th72/Thr81/Ser87 did not aggregate at all.",
      "key": "f968a7cc4c145d2058785223ab1753634ef68cfb6514407c7c3224b34ce503104138e0c7f88d850066d55fd126b6c46fff1017a6a2c1641b74c48e975996cad7",
      "line": 237,
      "relation": "increases",
      "source": 76,
      "target": 10
    },
    {
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "ASyngT75 and ASyngT81 formed rare, highly irregular aggregates, and the peptide tri-O-GlcNAcylated at all of Th72/Thr81/Ser87 did not aggregate at all.",
      "key": "14a75fc80165e49e5bcaca3d8ad12cf5ca4b054f704bbefdc8cd94a8369a1eda0b412a661f33bb048dd9060384081b70a765d8ab179e8f5479739ac58a48d55d",
      "line": 238,
      "relation": "causesNoChange",
      "source": 73,
      "target": 10
    },
    {
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "An unmodified control, ASyn68-77, significantly accelerated wild-type aggregation while the GlcNAcylated analogue did not.",
      "key": "773218f98b797bc6b82293cf3f8b3ddeca1a401c60ace4ae97fe0d499c6b4864bdafa58e9a758797a75517b3fdc76cffd49ef021f6c07831a15d29fc2cf83ab2",
      "line": 243,
      "relation": "increases",
      "source": 68,
      "target": 10
    },
    {
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "The authors suggested that OGlcNAcylation as studied in their case, had promoted oligomer-formation underlying the reduced aggregation",
      "key": "1664a6f1b32bd90dc8793d0abf4ed9cc4bdb0d5d90545455c781b789c274c05cc51a80bd669776998ddad8aca6cb121b46e79641841a11230450477fcdb5e523",
      "line": 268,
      "relation": "negativeCorrelation",
      "source": 12,
      "target": 10
    },
    {
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "Zhang and co-workers found that OGA inhibition via acute Thiamet-G treatment promoted phosphorylation of mTOR and AKT, leading to decreased autophagic flux and subsequent accretion of dysfunctional ASyn",
      "key": "13695b3a784a2c2a6f945d980357727bd07195332a699ae9416f4d88f560d1b18d0d8902f4f142da640106ab1869695675b1d25edf40da92e5d1b564b220353d",
      "line": 276,
      "relation": "decreases",
      "source": 64,
      "target": 33
    },
    {
      "key": "309c35f98f4ace7db5eb001053c2117eb1cd88b15143c70c638af33466fef1e8e76155fd83e16262185580e0e21fa9730c839587f5d32cd1b3319ffd97cd6512",
      "relation": "hasVariant",
      "source": 63,
      "target": 64
    },
    {
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "Subsequent re-activation of autophagy via rapamycin, an mTOR inhibitor, attenuated the increase in ASyn accumulation also.",
      "key": "aca9ece107cca35824e4575c3036075ec8dbf6b770aa284d1ec396161a9f52d4cdf1285a2794a6299f64e5248c81d864c9307451828519579aad1e7013d18179",
      "line": 290,
      "relation": "decreases",
      "source": 63,
      "subject": {
        "modifier": "Activity"
      },
      "target": 67
    },
    {
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "Zhang and co-workers found that OGA inhibition via acute Thiamet-G treatment promoted phosphorylation of mTOR and AKT, leading to decreased autophagic flux and subsequent accretion of dysfunctional ASyn",
      "key": "ac897ae061658c6cb9865ae1e1e9ccea4cefb2c5b4592ebf071eecca9ff2430b68e443e64dddf9434a127b597823867114130a685bf68975a386f3c0d9b1d77c",
      "line": 279,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 33,
      "target": 67
    },
    {
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "Subsequent re-activation of autophagy via rapamycin, an mTOR inhibitor, attenuated the increase in ASyn accumulation also.",
      "key": "7e8021c63e012a762c2607030c189a7e4a818d2573855bc43ce0dfc0f9ee54c6f7216894aa40c31482ac0872847970320beea381e57f83c2234bab2cb8d9850b",
      "line": 291,
      "relation": "increases",
      "source": 33,
      "target": 67
    },
    {
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "Zhang and co-workers found that OGA inhibition via acute Thiamet-G treatment promoted phosphorylation of mTOR and AKT, leading to decreased autophagic flux and subsequent accretion of dysfunctional ASyn",
      "key": "6a4e3028533ac8fe66388d921d1630b6977a472fc0fcab35734134d9cbc0bfb577776d2ef10baa0c2c379bc0df1318513c20ea884d40db827501a23780fecbdb",
      "line": 278,
      "relation": "decreases",
      "source": 48,
      "target": 33
    },
    {
      "key": "e116efc1e42b1489df61c436ffaafcd0372249b6e2dd4b3fe8b8586cae5efcc671048f5065d7e0a9164d380e4e7e449feee77aef4181eeb18af8d249b730ced3",
      "relation": "hasVariant",
      "source": 47,
      "target": 48
    },
    {
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "Subsequent re-activation of autophagy via rapamycin, an mTOR inhibitor, attenuated the increase in ASyn accumulation also.",
      "key": "e68936ac82732d68e5d62e79af0c2a4b84bfbd83fcb5a7491d0d562df7134b1a4350f612845b41e0a3d4ce1373cac343f70e1c03295e5824c4e43ee51c739f25",
      "line": 289,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 5,
      "target": 63
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Brain": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "Meanwhile, Vocadlo and co-workers reported that pharmacological inhibition of OGA, in each of neuroblastoma N2a cells, primary rat neurons, and a mouse brain, actually stimulates autophagy via an mTORindependent pathway",
      "key": "569d31f1496d9fa2f784fe38be8b91bd1c83e14ced7d8561e25176910912c4bbbe37e5c3b474a37b6cb5a9ea4fccd92c23f5796b894fde17bb5c4619a0db6d30",
      "line": 302,
      "relation": "decreases",
      "source": 94,
      "subject": {
        "modifier": "Activity"
      },
      "target": 33
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Neurons": true
        },
        "Species": {
          "10116": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "Meanwhile, Vocadlo and co-workers reported that pharmacological inhibition of OGA, in each of neuroblastoma N2a cells, primary rat neurons, and a mouse brain, actually stimulates autophagy via an mTORindependent pathway",
      "key": "d92017051511307653422f4bfa653b2bd726205bac54678cdc3b62fd9776209cf785dd2a27dff61cd5db69bb01ff203d452f313d7f3881fafbb3dbe3eb267d4c",
      "line": 307,
      "relation": "decreases",
      "source": 104,
      "subject": {
        "modifier": "Activity"
      },
      "target": 33
    },
    {
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "Phosphorylation of tau regulates its modulatory functions by impairing its ability to bind microtubules.",
      "key": "6d73e9a4744bce939be943641855e69e3e77c019db5e6941232dcf55d4b56bf603e629137c0e725f6846f6eaab19ef08831386c99266f00fe9ccf450361b6386",
      "line": 314,
      "relation": "decreases",
      "source": 60,
      "target": 36
    },
    {
      "key": "c4e71f1866eab20795e7e1d4b54fe09effb8b376e41712f8a130fe5192e07d83b0749cc2e2297b62cbea4bb7b1033909ea6d6423fa06166cb07543cee4249d48",
      "relation": "hasVariant",
      "source": 56,
      "target": 60
    },
    {
      "key": "e5d4041599e526e7adf923470964018d5c95f5767be385baa3323ee2085971d3b01f8e4f5d986aa59e600bca7a2f250ed966771af391e3d7416928b24049d42b",
      "relation": "hasVariant",
      "source": 56,
      "target": 59
    },
    {
      "key": "348aa6cf74f3896f16bc56b3e5aa368c8836aef39d7ea97e3b62a8743cb07ffa6c52e97ccc5236b55d6f86b885ca113cb8cd70d2a7704fc1f058697e69b66db2",
      "relation": "hasVariant",
      "source": 56,
      "target": 57
    },
    {
      "key": "1fcaab2a1c152de0d0a1becfa0776e9f2aaa2a74690bb940debd8dd10a8353274fd0a98711166720a203282bbd87df20931dbf499c3eea0c3630777396f450a4",
      "relation": "hasVariant",
      "source": 56,
      "target": 58
    },
    {
      "key": "43f3a05a562aea7d640aaac845125159fcfbdd06303b001b5cf1eec04af58dabda000353c3cf4551bae1aea91c8b1be6e3f2669e44287e4a25d0655b1d33aab4",
      "relation": "hasVariant",
      "source": 56,
      "target": 62
    },
    {
      "key": "09505215df0db1264915198df6f54ea647eb376b6ede05f22846b2d289a2907fa049769b8eb45a919e706a2eb7c7a96704537753eeb5e7c30a012888cd5296de",
      "relation": "hasVariant",
      "source": 56,
      "target": 61
    },
    {
      "key": "e30a63cb8051908bbf600613a93906b15c4705e7f7abe5a0ad62a2698f3a5262b6abcc9e9e0cf196429bd9a44486e8fc09c678ea23c20264267b728a4b6bb242",
      "relation": "hasComponent",
      "source": 36,
      "target": 17
    },
    {
      "key": "634e58096a5532932706dd2067ec8bba3b4f9fe5e640db2c3acaccb3b0e9efdaefea7e274911a0cf58de18a8e4b1fdc7e767f1b94021cfbd7dc9940098efdf19",
      "relation": "hasComponent",
      "source": 36,
      "target": 56
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Brain": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "Abnormal hyperphosphorylation of tau (P-tau) results in its detachment from microtubules, suppressing its activity and secondarily promoting its self-assembly into oligomers, ultimately giving rise to the NFTs present in the AD brain.",
      "key": "f7a9fe3a3f31113c2b4467aa5c420b8becfa91c97b41215921941e067adac8b1788f9471e74334ff42e16402adcdc568befe721340c1a0d1cfe65dfc122336b4",
      "line": 324,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 36,
      "target": 56
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Brain": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "Abnormal hyperphosphorylation of tau (P-tau) results in its detachment from microtubules, suppressing its activity and secondarily promoting its self-assembly into oligomers, ultimately giving rise to the NFTs present in the AD brain.",
      "key": "21c46c01637658ed89c70087d125dd710684799894935e8d359d0eabbcb7041484ac9d8ad572116798a481573721300cc9d41db1a906555ef031196e0bca442d",
      "line": 323,
      "relation": "decreases",
      "source": 59,
      "target": 36
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Brain": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "Abnormal hyperphosphorylation of tau (P-tau) results in its detachment from microtubules, suppressing its activity and secondarily promoting its self-assembly into oligomers, ultimately giving rise to the NFTs present in the AD brain.",
      "key": "76b218d021aed83fc6460d8ec6178b16dea764340d844f4379afcd387be39e33e6e6615ad19b2b33bfde8821b5ff76a62aa29a9a5c641cb3413efb1b5954bd3d",
      "line": 325,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 59,
      "target": 56
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Brain": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "Abnormal hyperphosphorylation of tau (P-tau) results in its detachment from microtubules, suppressing its activity and secondarily promoting its self-assembly into oligomers, ultimately giving rise to the NFTs present in the AD brain.",
      "key": "0aac663ee32ae92d751a4f69721f13b6af68c08da5d6d4c39dfda04df6fbc91c6a1ab778573c8e6cbb37300c59a4ac97ddf7cd2624db18ac2028c570a06808e8",
      "line": 326,
      "relation": "increases",
      "source": 59,
      "target": 9
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Brain": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "Abnormal hyperphosphorylation of tau (P-tau) results in its detachment from microtubules, suppressing its activity and secondarily promoting its self-assembly into oligomers, ultimately giving rise to the NFTs present in the AD brain.",
      "key": "0f317f8a548c06190ccdabbc87b9d11d5a16d0ce7e52a674524ae9253b36a782bea7952326c4b124b983d6459460849bff020d395a9289a529d4999858b02240",
      "line": 327,
      "relation": "increases",
      "source": 9,
      "target": 14
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Brain": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "Gong and co-workers identified that impaired brain glucose metabolism actually leads to neurofibrillary degeneration via downregulation of O-GlcNAcylation.",
      "key": "89ebdec50556a3d7d8ecdf04a29b03b17df57b7e444e8be21177aa62e7bcee6d72c759f295bd01bcb384ffdff9e61aebc62225d870d10f927e315d989a27239f",
      "line": 361,
      "relation": "negativeCorrelation",
      "source": 14,
      "subject": {
        "modifier": "Degradation"
      },
      "target": 84
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Brain": true
        },
        "Species": {
          "10116": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "It was later found that tau phosphorylation was inversely regulated by OGlcNAc addition in vitro, in tissue culture cells, and ex vivo in rat brain slices (Figure 4)",
      "key": "ccfc4e5f93d5ed00fa72c79454c699c997b39b39c045fe1021dd55e4f106dd337d9b3d14ad0e2265211c0f337c19ade387618aaf76dc7250aa1827fce296d47b",
      "line": 337,
      "relation": "negativeCorrelation",
      "source": 99,
      "target": 100
    },
    {
      "key": "ec9973011d81f016132c003df15ce976f48b4c6fdb8f275cbaebef4be4ee4091beebdfc97e584a49cc271399d639a3601415c141d0b8251018bfd4e331073c32",
      "relation": "hasVariant",
      "source": 98,
      "target": 99
    },
    {
      "key": "13dfd5e324e943b5b15969ee80cc94c2ee476ba98038149d2d3eea748cda06d59bc0296a07e95ac18a414ec8c83ff561354f04122550f1c3479a8907fea110a6",
      "relation": "hasVariant",
      "source": 98,
      "target": 100
    },
    {
      "key": "927676b9e87641b9e11f4087091b9253de770bc8336f4500eca8aacf50f248e1e8fe9ac7a4f09c0137d90614b8ae094b8be8fa626349ce8458e5d62ebcca62e0",
      "relation": "hasVariant",
      "source": 98,
      "target": 103
    },
    {
      "key": "2bba626db0242764c369450eec2de6d4628da74a9860db79f00d246975cd3b6c1a46422f649c3cac311a820a5200a9f45503e3e4a9c9f06ecc39e94ac01b0c36",
      "relation": "hasVariant",
      "source": 98,
      "target": 101
    },
    {
      "key": "88905dcaf316fafd54d6ac556028beb366a95a673c3bc102ca49fe43b6db25df6bd5af4f3ad10dedf7eef7e8d91877a80c2dec0f7e6620f2ade983427d108850",
      "relation": "hasVariant",
      "source": 98,
      "target": 102
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Brain": true
        },
        "Species": {
          "10116": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "It was later found that tau phosphorylation was inversely regulated by OGlcNAc addition in vitro, in tissue culture cells, and ex vivo in rat brain slices (Figure 4)",
      "key": "87679fc0b8abc306d2cf01da660aad0daddacbb577ffac65d86668bfc00e617da3808bb14d890ad241c19616cb3cdbf75373acbfc3be0b7bfb15f69b09c50714",
      "line": 337,
      "relation": "negativeCorrelation",
      "source": 100,
      "target": 99
    },
    {
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "Furthermore, downregulation of OGT leads to increased tau phosphorylation and onset of AD pathology.",
      "key": "3a5fd185e6181074b267f79dc77e375b435342d89198f70be8783e05ad4e869f92e178e0391889a323ca0954dd9f677ee255fb1811a6f5180d3a873b0660e44e",
      "line": 344,
      "object": {
        "modifier": "Activity"
      },
      "relation": "negativeCorrelation",
      "source": 106,
      "target": 66
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Cerebral Cortex": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "Finally, AD patient cortical brain tissues reportedly have significantly reduced levels of OGT expression compared to aged and post-mortem delay matched brain tissue.",
      "key": "0aa55cee252f742b3709bca7c08270b59a1e230d94b81ee53d74fcdfa452cce16efa22ff39e0e5848cd6e36833a9a7bb20bb7444b03f59a5f724124392421254",
      "line": 369,
      "relation": "decreases",
      "source": 106,
      "target": 66
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Hippocampus": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "Twelve-month old triple-tg mice (3xTg-Ad) displayed reduced levels of tau O-GlcNAcylation consistent with tau hyperphosphorylation in the hippocampus.",
      "key": "466dd9395ab15bda2c888f767643d84795c8e74c90ceb523c11eb75ff9f9a3f55ae4ff764cc5e6f914671290d4ba1b64d468cd6830a8b3b6fce4156a0434d6f6",
      "line": 351,
      "relation": "negativeCorrelation",
      "source": 86,
      "target": 87
    },
    {
      "key": "2f143577bbe7d84527de8809a76373211b4d314969f571e7269c76789923b6224993e53e166ba7171d056c662fd548073712c4937e129e79ba15802c408cb614",
      "relation": "hasVariant",
      "source": 85,
      "target": 86
    },
    {
      "key": "1fa1b65dc3e5e4831d66c47e17e6e8ac502d1d2517c5f3b2c62ea024b006f644253de493a20a8ee8649cbff19f13edfa9d7df2797000296915dce340ed72ed50",
      "relation": "hasVariant",
      "source": 85,
      "target": 87
    },
    {
      "key": "b534fd9f3f746602fb748406ef4b5135a4ea2f5fa6346dd607bc73ff17e18ed5a8a2942e974a4f9a855d3991744e5f882cb5d7d84707906e50ee2c7a8aa21045",
      "relation": "hasVariant",
      "source": 85,
      "target": 89
    },
    {
      "key": "d187eddfa057d37d306253aea760ee6848ad2d39429ba367a63a2b2a2e6c1799a7f44fb446c5486199ae5765ee06886b66579a09a26beb7bae6166b37bf79abc",
      "relation": "hasVariant",
      "source": 85,
      "target": 93
    },
    {
      "key": "ee62c43bf8d8c6574e136fbd6c305a4c92a8bad7aa0cc5202b377cb29302b4b2dc75e76eec88a731a8f89ae254f0783d97c8ee971531f2f306a37e1eb0668cd3",
      "relation": "hasVariant",
      "source": 85,
      "target": 90
    },
    {
      "key": "236e073bbb571677b2ad9f7f80b447ada7dcb730abdc1d692dd2903d85d543a9acbc9dbec0da53221727d9a5f7df3e3aaeed7a4f34d272eb69c6e014dbf77618",
      "relation": "hasVariant",
      "source": 85,
      "target": 91
    },
    {
      "key": "f177ac97183e576dbee606fc7e8d19c6784616bf4f9f0efea20728a9ca1cedd2b404dfbeaabda7b632679871275e7708a1cc0c2ec51c597e5fc128f5d6d0c9ab",
      "relation": "hasVariant",
      "source": 85,
      "target": 92
    },
    {
      "key": "2c2ea9b1bf222f9bdc74a04eea4aea1ce45cab18586adb11e8c9889ab3c25edcd3db437e123224f5555bba399383b0c940ffbabee03881d8e5f45b8c2605a862",
      "relation": "hasVariant",
      "source": 85,
      "target": 88
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Hippocampus": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "Twelve-month old triple-tg mice (3xTg-Ad) displayed reduced levels of tau O-GlcNAcylation consistent with tau hyperphosphorylation in the hippocampus.",
      "key": "4106f3f2efa9c371812f3743f6c75d76c7c7e960814c77ef35a1141591df8e76fae02c09cd09a5d2b0e6fc7685671f6b9233f659ce580b59ea8b5dd2d4e8e0a7",
      "line": 351,
      "relation": "negativeCorrelation",
      "source": 87,
      "target": 86
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Brain": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "Gong and co-workers identified that impaired brain glucose metabolism actually leads to neurofibrillary degeneration via downregulation of O-GlcNAcylation.",
      "key": "acc4e19c0f87713aacfab24ed35179e2f8bc2bc7fc9e0f044ab3be44fc1ad63465356a08d3dba5f933821010a30b1a2fa0b30703cb3e305c9005cb324c0fed5a",
      "line": 360,
      "relation": "association",
      "source": 28,
      "target": 84
    },
    {
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "Beyond inhibiting its phosphorylation, the O-GlcNAc modification hinders tau oligomerization",
      "key": "4798df972bdd24a8e3198a971502ec8be988c1f12007b330a74247bd7fde102dd0afb640285bc6ae02a4c2f5240b2ea6352d61a7f36aa2402ae0f626da8a28cd",
      "line": 374,
      "relation": "decreases",
      "source": 57,
      "target": 60
    },
    {
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "Beyond inhibiting its phosphorylation, the O-GlcNAc modification hinders tau oligomerization",
      "key": "9b36b03921615525e9d8442e25094a960f708d4813d2261fce03ab6588adec1f9a77fd49adba8b20fd452acef7fa597771450f4cd7403a4ef33337f3f077bac7",
      "line": 375,
      "relation": "decreases",
      "source": 57,
      "target": 9
    },
    {
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "Vocadlo and co-workers demonstrated that a recombinantly produced O-GlcNAc-modified tau construct (spanning residues 244- 441) formed oligomers at a slower rate, and to a lesser extent than the unmodified, recombinant control sequence during ThS fluorescence assays.",
      "key": "dd36ab18731871d5983746ee97a36d91b512c97af96792f6a4ff55a3c9cec87723372ba6fab2c3ce703f2c33175e6429518a424d3393fda7b9ef9fbef5601e0b",
      "line": 381,
      "relation": "decreases",
      "source": 57,
      "target": 9
    },
    {
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "Indeed, O-GlcNAc modification of tau-441 appeared to slow tauâs extension, perturbing the equilibrium position between oligomeric and free tau.",
      "key": "a1b344c0704027d1e0015db81a58db6b8c98848eb2de8df368c81f4671fb63e923899994b608bd8d06f5dadfc2a3a3b2fab012f2a7d42e7fbbeb938c01df8f9e",
      "line": 387,
      "relation": "decreases",
      "source": 41,
      "target": 9
    },
    {
      "key": "904d085c044a2624b1b1f3c22b15e2830679114d00a0a2a1bbcb6887115df4bc6a000da536ea1e91246e8b3534cf8e27c6a15ad833d425bd6760e1bae28c207b",
      "relation": "hasVariant",
      "source": 40,
      "target": 41
    },
    {
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "Results suggest O-GlcNAc modification at specifically Ser400 plays a critical role in hindering aggregation",
      "key": "5eaef942d4093c7dad08d9275f550524fab609877f4a3dd63f77a80eaa2b0d5017573adb46e0d960c3947adbb5ed6deca4867bd0daf79758a4beb136f8665ef3",
      "line": 391,
      "relation": "association",
      "source": 58,
      "target": 7
    },
    {
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "Results suggest O-GlcNAc modification at specifically Ser400 plays a critical role in hindering aggregation",
      "key": "2171d37871ff56d29f52f96620c3e5ebfa9c0e4b47a9a7c36e353fbc0e51f78d030e51f4fe83956a9171853d4587830f4777d9df2d78559d388ca313accf02cb",
      "line": 391,
      "relation": "association",
      "source": 7,
      "target": 58
    },
    {
      "annotations": {
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "Gazit, Segal and co-workers reported that their synthetic, O-GlcNAcylated PHF6 analogue, besides possessing reduced self-assembly propensity, seemed to inhibit unmodified PHF6 fibril formation upon co-incubation",
      "key": "9bc8ac000cbd2b821267e7393bc56239259ac24a7d3ff77821ea57fbf7f3da740e1ee0cd2cb3d00d9283acd2eac2cf58e933ffc515f5965a614ce9309a0b6aeb",
      "line": 465,
      "relation": "decreases",
      "source": 43,
      "target": 37
    },
    {
      "annotations": {
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "Gazit, Segal and co-workers reported that their synthetic, O-GlcNAcylated PHF6 analogue, besides possessing reduced self-assembly propensity, seemed to inhibit unmodified PHF6 fibril formation upon co-incubation",
      "key": "6e4e0612fdfb021eff3f5b2524857aedbdcec90b147c0795e2b3dd5b138eef41a792682d719502c9be502b39c63c0bd4c2c49ada19f4bdaea6d13eac7d2c3f75",
      "line": 466,
      "relation": "decreases",
      "source": 43,
      "target": 8
    },
    {
      "key": "64dfc63284eb98ad2f5edb86041f4f27d7e4702ffb45a0289433be02c90357335da57ed1112ceec68e40f4d7a0339c851ff72a08a9408c084822956ba3e1c3d1",
      "relation": "hasVariant",
      "source": 42,
      "target": 43
    },
    {
      "key": "26d89ce1c72b286b31e2a1cee281a2332da589312275d0f19672b8b000a9e6c12293d7f7927611f7db8d637032181a044336db10d2ea75303c967bc3776ac914",
      "relation": "hasComponent",
      "source": 37,
      "target": 42
    },
    {
      "annotations": {
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "An inverse correlation between O-GlcNAcylation and AÎ² formation was reported",
      "key": "64ced0596882046c2767ea4439f26d975adf79a241165b993ef92c707e0064bdf6010082a86ea93287112da0bbd43974fdd9b334bd11ccee572ecb514ddab187",
      "line": 482,
      "relation": "negativeCorrelation",
      "source": 51,
      "target": 1
    },
    {
      "key": "306907cddb544e21922a39eec5f97c800e072a0700a9b7004ee070fa241b93fdbf84c5a8e09970d83aed0b577dc0b6f8c7392d58567bfca2ecc386638a8be0b6",
      "relation": "hasVariant",
      "source": 49,
      "target": 51
    },
    {
      "key": "b30d71e25b64f22341dc7e78130ecbf18a3dd2e0f58676c3d03a4d1fab8814a2d807ddc05cae302c7d0b860b755f1415b0cbcfe3efc70e0de2c4954558765387",
      "relation": "hasVariant",
      "source": 49,
      "target": 50
    },
    {
      "annotations": {
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "An inverse correlation between O-GlcNAcylation and AÎ² formation was reported",
      "key": "f88d2e0205da5d65ef87e297b2396497d81254282353dc9e99c1b6155168fbf8c73e3a7fcc9ee814baf20023681046eca2de8bb29913e0b5df717fa8def9e1bf",
      "line": 482,
      "relation": "negativeCorrelation",
      "source": 1,
      "target": 51
    },
    {
      "annotations": {
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "Thiamet-G treatment of tg TAPP (tau/APP) mice blocked cognitive decline paralleling decreased AÎ² and plaque levels while not affecting tau phosphorylation",
      "key": "28551c49cefbb8e141e1243c38b97abcca5810c137acf99c8e4a9445bcb4be2bdfce13e9082e01d5ed475b70c10fdc26c65bd54f62634fede3f3a7e82e9ef71f",
      "line": 512,
      "relation": "association",
      "source": 1,
      "target": 34
    },
    {
      "annotations": {
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "Treatment of the 5xFAD AÎ² mouse model with NButGT, another studied OGA inhibitor, impaired AÎ² production and attenuated activated gliosis",
      "key": "2be92913f709771bac2b2bdce91c069b7ebab24e4e792d3facd167fa51a8900391642e8c2a27de43297c36d827bcb77dfd45a1bd6c405a0b808500e580543516",
      "line": 487,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 18,
      "target": 65
    },
    {
      "annotations": {
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "Treatment of the 5xFAD AÎ² mouse model with NButGT, another studied OGA inhibitor, impaired AÎ² production and attenuated activated gliosis",
      "key": "bdfe4b10b32afd3dd34d74536a35cc7e67d401a4a23bf9650a9455fad51bcdfeaa0d461c1547dcd75fddb7afc108c6b1868d46b62e0a32893e3ff4c20d12322b",
      "line": 488,
      "relation": "decreases",
      "source": 18,
      "target": 1
    },
    {
      "annotations": {
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "Treatment of the 5xFAD AÎ² mouse model with NButGT, another studied OGA inhibitor, impaired AÎ² production and attenuated activated gliosis",
      "key": "c550ab0908f923f8b543a53522c4475c7e35078c5247f492ab0e6af0cc895961b1554c779514e43723f6d1991e3489b4ed668ca734ceb0bba13d2a8ed5ee1c66",
      "line": 489,
      "relation": "decreases",
      "source": 18,
      "target": 110
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Spinal Cord": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "Treatment of even the mSOD mice with an OGA inhibitor, NButGT, increased levels of O-GlcNAc in the spinal cord.",
      "key": "a3351b269ef4011975cfead6cbf5f54c3e49d41b98157b75065199916956adb7ab8ee8d1a6bcc52132b656706da35a7b1dd9f00b04732df6ef1c1022283e4bf2",
      "line": 569,
      "relation": "increases",
      "source": 18,
      "target": 96
    },
    {
      "annotations": {
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "Thiamet-G treatment of tg TAPP (tau/APP) mice blocked cognitive decline paralleling decreased AÎ² and plaque levels while not affecting tau phosphorylation",
      "key": "1821badd1ffa410f82ac214bb8147a17f924c1be76fe866e5fcb3f1a136466319ad47c81cd6cf9d640de81e297b55f7be7dd88e2ea76b0d3851d0925134275ca",
      "line": 512,
      "relation": "association",
      "source": 34,
      "target": 1
    },
    {
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "Finally, treatment with prostaglandin J2 (PGJ2), an endogenous mediator of inflammation that promotes cleavage of secreted APP, is reported to increase overall levels of protein O-GlcNAcylation.",
      "key": "99dd48e2d82fc55425444a3df584c07a4cb02fcd1db69460bdeea8194683ed0e6c49a1df5dfebdbf1bb69fb1e38afccc0ea4dba0f4b03606ffb0538ab72c7dfe",
      "line": 520,
      "relation": "regulates",
      "source": 2,
      "target": 113
    },
    {
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "Finally, treatment with prostaglandin J2 (PGJ2), an endogenous mediator of inflammation that promotes cleavage of secreted APP, is reported to increase overall levels of protein O-GlcNAcylation.",
      "key": "7c703f1a0a9763113cc8a3560fbeb92714ee32be28f76eee82f345f2845137fdacf9b373c5f51400735529b59295ee3aa09fb2b5085d7f62aaffc42de9868975",
      "line": 521,
      "relation": "increases",
      "source": 2,
      "target": 50
    },
    {
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "Finally, treatment with prostaglandin J2 (PGJ2), an endogenous mediator of inflammation that promotes cleavage of secreted APP, is reported to increase overall levels of protein O-GlcNAcylation.",
      "key": "9d217271567147e862e751c13346062113ec23aab70ef436fdd149f6192b1f49744e3d0832c15c9bda683c66201858e1b17a8699c48db9a1595637b73190d153",
      "line": 522,
      "relation": "increases",
      "source": 2,
      "target": 51
    },
    {
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "Normal huntingtin plays a role in vesicular transport, transcription of neuronal genes and production of brain-derived neurotrophic factor (BDNF), besides potentially also possessing some anti-apoptotic function.",
      "key": "c40bb7b97e95ed763c5f0c7e3bc6446fd64dd14ef49eac708da4372ed6aa39a54207bcd819b235fff8f1dd25865562e4f3d35f24353ec2e971d6430a5edeb4a3",
      "line": 529,
      "relation": "association",
      "source": 53,
      "target": 32
    },
    {
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "Normal huntingtin plays a role in vesicular transport, transcription of neuronal genes and production of brain-derived neurotrophic factor (BDNF), besides potentially also possessing some anti-apoptotic function.",
      "key": "9dc159907504aca6201471b56e79633b730dc72f8aee6668ff59402b13907f54866771c53e65cadc5ff2c2953c5ebb240e60c6de4fd6c4a571446627f6b27c21",
      "line": 530,
      "relation": "association",
      "source": 53,
      "target": 52
    },
    {
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "Normal huntingtin plays a role in vesicular transport, transcription of neuronal genes and production of brain-derived neurotrophic factor (BDNF), besides potentially also possessing some anti-apoptotic function.",
      "key": "b67c3656463b25122f44ffd2d10e01db9879fab7ba8a564992157d82f04cac920854f63d931f11b342f61083be36c8a6601bccdeb17a77a0e96ee7534d2a5290",
      "line": 531,
      "relation": "decreases",
      "source": 53,
      "target": 24
    },
    {
      "key": "46ede6721769a6d22221fb89291a5c9315d8a74e734df807b36d44951c05cd10a7cdff3c1a3f906ab0a973e5dd05727839aa74f4a3c5798f5f6555dd7f8facd5",
      "relation": "hasVariant",
      "source": 53,
      "target": 54
    },
    {
      "key": "a3ac61ee6ec4e9b3af47845dbe04b3de658393e1d87be866f3fc491ce0722391f8d21e748e8816d98859b534dff8a41ea1d7df7603199741e1d45d50c1675f96",
      "relation": "hasVariant",
      "source": 53,
      "target": 55
    },
    {
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "Normal huntingtin plays a role in vesicular transport, transcription of neuronal genes and production of brain-derived neurotrophic factor (BDNF), besides potentially also possessing some anti-apoptotic function.",
      "key": "fcf8ac3b9fbde470c121b909975b16cee6b68ab81ad7ab203801a41a56400c1629bccc7b367aa9ee29080da778267509fdcc52ec284bc811c11837963355dfab",
      "line": 529,
      "relation": "association",
      "source": 32,
      "target": 53
    },
    {
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "Normal huntingtin plays a role in vesicular transport, transcription of neuronal genes and production of brain-derived neurotrophic factor (BDNF), besides potentially also possessing some anti-apoptotic function.",
      "key": "bff87fafa9fc55a1092ed376bfa0066a0fcc7c80862cf6a025aca6ab5be49b0feb5d1026727c8cfd5575475b20360f9f8d6c2d8660a6011e7399b7d77ed36d2a",
      "line": 530,
      "relation": "association",
      "source": 52,
      "target": 53
    },
    {
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "Instead, decreases in global O-GlcNAcylation levels is reported to be protective against huntingtin aggregation and cytotoxicity in neuroblastoma cells and fly models",
      "key": "dae0019878a0004e2498f1f00b9f941aaa8f6419f8877118cc3d51486c53ac3bf486931327028f1dec3988d65da4a1e3efd869a264c280b7c7f7e7579b2c392a",
      "line": 536,
      "relation": "increases",
      "source": 54,
      "target": 13
    },
    {
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "Decreasing O-GlcNAcylation enhances autophagosomelysosome function, which leads to increased basal autophagy flux and clearance of toxic huntingtin aggregates",
      "key": "4226d0890588d300c78442e8af79a06c5a15b44b32e837dc03d397449d52e0d434600cd18903c8ea52ae53cb52d9b7daabc46c9c60e8d761a1fa4c818490e8a0",
      "line": 542,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "decreases",
      "source": 54,
      "target": 13
    },
    {
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "Decreasing O-GlcNAcylation enhances autophagosomelysosome function, which leads to increased basal autophagy flux and clearance of toxic huntingtin aggregates",
      "key": "9d60ae56f1ca55c343b8528d2598643202677e0f1c6c9fd004475ade14ba03fc194e4b03b4eb21b7aee7337bad5db490dd678d7296b312cd21c8dc7167d10048",
      "line": 540,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 54,
      "target": 16
    },
    {
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "Decreasing O-GlcNAcylation enhances autophagosomelysosome function, which leads to increased basal autophagy flux and clearance of toxic huntingtin aggregates",
      "key": "f53f4c73edff948e1b88c535bb48e722dec6d901b52907e3d5337a8f4b04302575b05e993610bb465da9f1c1b10afe12acda10b56e0f78c6195db54ecbc8acbe",
      "line": 541,
      "relation": "decreases",
      "source": 54,
      "target": 33
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Spinal Cord": true
        },
        "MeSHDisease": {
          "Amyotrophic Lateral Sclerosis": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "Mice carrying a mutation in superoxide dismutase 1 (SOD1) also exhibit decreased OGlcNAc levels in the spinal cord",
      "key": "93ff541bb51432e8f42d0dd54f840c4425b532db47a46ee72649d7e1804ff13fcc8135a2156e73fba0d4e286603b915f91c394f9b42bdf7c00a065c28febb72e",
      "line": 555,
      "relation": "decreases",
      "source": 97,
      "target": 96
    },
    {
      "key": "354c324604cb85b588ae948467ce5a25f65a599fffae101ea39986bc8f685c9dc1a0039cb5447098220b6c03ef558e3b43b659a141adf56664ac1906a3877770",
      "relation": "hasVariant",
      "source": 95,
      "target": 97
    },
    {
      "key": "b4d5e06094fd0279efa5731aea0ef11a8add5a7fa142d110b9057e88bfac3c9654acc5a0f214bba3df838b08925dc2920b42d63789e7959916bca5d3231742e7",
      "relation": "hasVariant",
      "source": 95,
      "target": 96
    },
    {
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "last": "Rudrawar S",
        "name": "ACS chemical neuroscience",
        "pages": "2209-2221",
        "reference": "30985105",
        "title": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "Familial SOD1 mutations are responsible for 20% of familial ALS cases in humans",
      "key": "3034b6c06e9bcf60a9a6965d0e3d95921740253d5d7bd494c4a1d967ae950d7b60adb78f11eed7d485adc045e2b637d8097a8ae743b1b661531ec4d3d68056dc",
      "line": 562,
      "relation": "increases",
      "source": 80,
      "target": 107
    },
    {
      "key": "ac635f17f31ec93b9300cee1d38cdeeed57dee8049983c025a490f45198a7ce226ce24152230546583247d61980363aab127361f19888b49910296c9d4b46dbb",
      "relation": "hasVariant",
      "source": 79,
      "target": 80
    }
  ],
  "multigraph": true,
  "nodes": [
    {
      "bel": "a(CHEBI:\"amyloid-beta polypeptide 40\")",
      "function": "Abundance",
      "id": "2ca2eb795438fe9e0f24c1e9d332717de5e344ddfee00ce8df89c5b901d85db5994d6ffd383e40a90bde264f33e75b220476b3de86c89f0658bf281c872f0bb6",
      "name": "amyloid-beta polypeptide 40",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(CHEBI:\"amyloid-beta\")",
      "function": "Abundance",
      "id": "a9487b29439483c6840095610dd3e496e3ca9cccc3a8d71e0385a39b570f3c0a26965ac06d83265e1c08deaae7998272d4f4c21ec0534f8be3fd8e4e57dbb3a2",
      "name": "amyloid-beta",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(CHEBI:\"prostaglandin J2\")",
      "function": "Abundance",
      "id": "f6b5858083f34929d007ae8bbc5fac382dab059176c715b143f8c923a9b35bcdd30d96c0e1982a65115f9624f19cf0ecdf42ee77162f8153f38aae80702cb875",
      "name": "prostaglandin J2",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(CHEBI:glucose)",
      "function": "Abundance",
      "id": "ad228f723834a0438254651fae75410bfa5cb8ee6d9baa98af0240115b1e5ec55edb5d001429c764d8785ec034b6b90edc76a4b83d14572cae3624feacf85491",
      "name": "glucose",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(CHEBI:phospholipid)",
      "function": "Abundance",
      "id": "059b31b0fcdfbb214b0e54d633c669f863f64083c7c8f10e294c0a7ce61e436804ab8d9283481a98ea92c40aaea4b3ff4aec7a95824a8f4a292bd2094f75eba4",
      "name": "phospholipid",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(CHEBI:sirolimus)",
      "function": "Abundance",
      "id": "102b031a00eed78fd9e5c4236defb90a8995463980f9060493bb5fd3159a3eb666cbb2b6a33a213c749a2b279ef6d149796b4f0b568e03b82eb5c89b0da77426",
      "name": "sirolimus",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(CONSO:\"Dopaminergic cell groups\")",
      "function": "Abundance",
      "id": "66c0e1b6c395e7c04650f06163a8f44cce0366f1269fd5623c44391850311f24e263be053fcefe11ec891bb6f6317517c28ad8692dca87932d0a52e1917ce559",
      "name": "Dopaminergic cell groups",
      "namespace": "CONSO"
    },
    {
      "bel": "a(CONSO:\"Tau aggregates\")",
      "function": "Abundance",
      "id": "102bd40eb29c18f3cd2b3c48aa1a96afad05e01e0f8090172738d382dcfa933ac25a510484a34dd66c94587194ad5f9d99148b59a7741edc83871b3edf50ed4e",
      "name": "Tau aggregates",
      "namespace": "CONSO"
    },
    {
      "bel": "a(CONSO:\"Tau fibrils\")",
      "function": "Abundance",
      "id": "f3e8c343c75966e6013edd4b44b138d833a31d71114c9ee4321e4bd7240935cd2fd1a1599071e9669e17aa56805ccc44bffe4d338f261adfde87a72105059d95",
      "name": "Tau fibrils",
      "namespace": "CONSO"
    },
    {
      "bel": "a(CONSO:\"Tau oligomers\")",
      "function": "Abundance",
      "id": "e9f53522ae92cf8d207d2d4c497e7586fed3ec49be71928b33d79c1df78ea4a46baccab2e07d8b8e99bbd19df0e69b0cdaf8fe0ce33b0c00993e202491f6a4bf",
      "name": "Tau oligomers",
      "namespace": "CONSO"
    },
    {
      "bel": "a(CONSO:\"alpha-synuclein aggregates\")",
      "function": "Abundance",
      "id": "8458de4387ffee68f57c04b0c48da5c3aba9b9d0dd68f64fc25b943486262a6bfd558dc27d4623d4a3f41182b1bb02ea975bc7fad9e9f7516c511291f9e64043",
      "name": "alpha-synuclein aggregates",
      "namespace": "CONSO"
    },
    {
      "bel": "a(CONSO:\"alpha-synuclein fibrils\")",
      "function": "Abundance",
      "id": "b67ba957bbd4b340637ea22bb49bbcde88e3a38af5b37ba136e6967ebaf6549b789b73e2e4f0134708c4807b12999346b0b8f5969583b157e4c1bc8243e877e8",
      "name": "alpha-synuclein fibrils",
      "namespace": "CONSO"
    },
    {
      "bel": "a(CONSO:\"alpha-synuclein oligomers\")",
      "function": "Abundance",
      "id": "4aeeb857695e9a5f552484c25ebe20ba0aac91386e47ac2b81511ea80d17e4255ba82b4e4192de60b6af8f30c22eb8334a3a66a0a6d750cb85892d397af4c7a9",
      "name": "alpha-synuclein oligomers",
      "namespace": "CONSO"
    },
    {
      "bel": "a(CONSO:\"huntingtin aggregates\")",
      "function": "Abundance",
      "id": "5352908cf2f1b5e2a59707ab44a30a859e700bbcc03b6e3ddd55f89d20bcc4b330ceb8f5b45ced0c4437ae884ae08534f59156415298fb3a1a2f05b11c1dba33",
      "name": "huntingtin aggregates",
      "namespace": "CONSO"
    },
    {
      "bel": "a(GO:\"neurofibrillary tangle\")",
      "function": "Abundance",
      "id": "3b50c674ff9633f408e5173562a06cf3a856abc95a8b034db8e940b464f1cea72df6f9fa9b7b02b5daf4eb86a37a155f203289451f7203a7b9c9e6c65313eadf",
      "name": "neurofibrillary tangle",
      "namespace": "GO"
    },
    {
      "bel": "a(GO:\"synaptic vesicle\")",
      "function": "Abundance",
      "id": "d145f42b1cf3732a644e504e8c09e68f21a2a7456136505a45e9eb8938e9f8279c86b95caa6feb96f8aa2d4771f263ca1f9820bd13f66df04f9ea377f1581406",
      "name": "synaptic vesicle",
      "namespace": "GO"
    },
    {
      "bel": "a(GO:autophagosome)",
      "function": "Abundance",
      "id": "715a4a43d0864573b89131b448d7cc46791ca779974c2ada17b881dda1dcdf4e67fc60a7c5d777ea65d035c51f0048585689c1917866dc437cb2e24c943a61ed",
      "name": "autophagosome",
      "namespace": "GO"
    },
    {
      "bel": "a(GO:microtubule)",
      "function": "Abundance",
      "id": "0c753f37efe0eb149a47a1dd700eda093a03b462374275c68480b6aed3be0f81aa9793a179dfd97f8e0834f1fb9be4b4a6cff2165b176d9e8a8744f5e0d5bc2c",
      "name": "microtubule",
      "namespace": "GO"
    },
    {
      "bel": "a(MESH:\"1,2-dideoxy-2'-propylglucopyranoso(2,1-d)-delta 2'-thiazoline\")",
      "function": "Abundance",
      "id": "83a00a7050ab0c8a7b8732b2fb8f2c3cfa96fa003248b3166cb920ff2f58ac5f6807b2155a1be36b23294039234366f23dc17fcc1618b5e9dc614a6086e6ee2f",
      "name": "1,2-dideoxy-2'-propylglucopyranoso(2,1-d)-delta 2'-thiazoline",
      "namespace": "MESH"
    },
    {
      "bel": "a(MESH:Hexosaminidases)",
      "function": "Abundance",
      "id": "9bc1d10e643534a98bce1fcc5e2cb946f15c3ba187596190733b557bc99de4f873ffb7769edc7227d27777ace4ff5e1b64f848300829efea82c2070307d2dd2b",
      "name": "Hexosaminidases",
      "namespace": "MESH"
    },
    {
      "bel": "a(PUBCHEM:135566354)",
      "function": "Abundance",
      "id": "d40a1eb941f037ccf4bc396777654ac58cb3c20883284510103cd2d78d3af96398b935b28a4f1e4ba8f83f2727abe87fa53af25d3b3d73a657f3a326a2d7e1cc",
      "name": "135566354",
      "namespace": "PUBCHEM"
    },
    {
      "bel": "a(PUBCHEM:9576811)",
      "function": "Abundance",
      "id": "9e3a7b7200a996efdc5df44b5743b0bb05cd3bd1f12a3f2353eecc1f1daf66bde0397fdc2d429be23627821b655eb39e744a01cf9b564f12190b8027a2af0e87",
      "name": "9576811",
      "namespace": "PUBCHEM"
    },
    {
      "bel": "bp(CONSO:\"APP processing\")",
      "function": "BiologicalProcess",
      "id": "62711cb0430d958ea1df74758e562e82ffbb815b3b9f5207a6675c49650e270d61dc34f2d7bdcce4859af35ff242b211f605dbcae46aa03b788fb8adc7114f7f",
      "name": "APP processing",
      "namespace": "CONSO"
    },
    {
      "bel": "bp(GO:\"SNARE complex assembly\")",
      "function": "BiologicalProcess",
      "id": "9506343118b89e3c2d0f6096737619c09ae10443020ba8824d5c042ed7464f007435e93f03b8eefcdc590601c7efaef863b3a8fac45866e006426f88ee882124",
      "name": "SNARE complex assembly",
      "namespace": "GO"
    },
    {
      "bel": "bp(GO:\"apoptotic process\")",
      "function": "BiologicalProcess",
      "id": "1c5172472cbecf29eeb8e86a4cac2d13123fe572356f00e2f98302422560bbda2854e3b1f8fdf85396655393cf5ddb42e0db210c3d3fc146fa358cc8d0ed0254",
      "name": "apoptotic process",
      "namespace": "GO"
    },
    {
      "bel": "bp(GO:\"brain development\")",
      "function": "BiologicalProcess",
      "id": "25cc1c3cfa4fc89f3429743927ae418ae3277146e10022e0b21235bc54289a2eb4b4d561714971be822191f1f1b17e9a5de5e34d1031284ca59c2eb0240daf7d",
      "name": "brain development",
      "namespace": "GO"
    },
    {
      "bel": "bp(GO:\"cellular glucose homeostasis\")",
      "function": "BiologicalProcess",
      "id": "fd1ea74b3d643a32c1795368d5c769f47e0fedc70d256f41aefbd79daef4b50df37e2629efc39d0bdfb904da08a8e1fe83b5f1a959a3fa84528c6bde3ad25bdd",
      "name": "cellular glucose homeostasis",
      "namespace": "GO"
    },
    {
      "bel": "bp(GO:\"dopamine secretion\")",
      "function": "BiologicalProcess",
      "id": "677a4a705049f2c365df0ce1891506f776505e8e9936b96c1a6dbae1fbfac951848b0de2762d7bcfdb5b6ac451251927ead172a83d29522d73c4f0b51801010c",
      "name": "dopamine secretion",
      "namespace": "GO"
    },
    {
      "bel": "bp(GO:\"glucose metabolic process\")",
      "function": "BiologicalProcess",
      "id": "6681cf02278d39bd743eb5de75ec62487ae3b5c20d67d093d8eac248b88f7f481874541876ec7942d3430b054ebe491b1737e811ade8aad646f60cc638344ac1",
      "name": "glucose metabolic process",
      "namespace": "GO"
    },
    {
      "bel": "bp(GO:\"motor behavior\")",
      "function": "BiologicalProcess",
      "id": "181472b7f9a4b32696b87492619020f88bad9e24f439e97158614801e3fb1dda434c97b95c252baa65a43ba7d78eecfca26f91f6a5295d37b21e6873f04a73f6",
      "name": "motor behavior",
      "namespace": "GO"
    },
    {
      "bel": "bp(GO:\"neuron death\")",
      "function": "BiologicalProcess",
      "id": "ad7c90f2bc746a5118759fd1c8857478c02207d574a26faaac9d6e4d6fa4661d8d87446139db0024a4011aae26027d3cabdfba663aec0ac0a8242868efb81dcd",
      "name": "neuron death",
      "namespace": "GO"
    },
    {
      "bel": "bp(GO:\"protein phosphorylation\")",
      "function": "BiologicalProcess",
      "id": "abf09aab1363aec3089a1380f7ed21622b29ab8fa39c40dd6e8587bf8a250812887e207483b9da6d7e6a848daf919cfa3e76ae11ed4ab1014ec442e014b30a4d",
      "name": "protein phosphorylation",
      "namespace": "GO"
    },
    {
      "bel": "bp(GO:\"vesicle transport along microtubule\")",
      "function": "BiologicalProcess",
      "id": "aa364cea64268b9c78bbedb52486cea7fd1c58af6ffca221feca1b3af6294d9024e724c3594513eb36b362d3e588ed0daa05d4c3e5c2cc27aa0bce4906c6a23f",
      "name": "vesicle transport along microtubule",
      "namespace": "GO"
    },
    {
      "bel": "bp(GO:autophagy)",
      "function": "BiologicalProcess",
      "id": "f1a3202be460e565f65c1445ee061e99f63cc05f9ab70c5d4d8d93ba180d6a94f65cb8d1ac6c5ba53c0a4d2e153db32135e6a0bffcfdfd4d84e6727594a70b0a",
      "name": "autophagy",
      "namespace": "GO"
    },
    {
      "bel": "bp(GO:cognition)",
      "function": "BiologicalProcess",
      "id": "8d73f2caa1c473289d5f37cbdd4ad391a120cdbdf2356b373070c2a7b2bc0c785eaa620782fa2dd947c666100f0a169e81f35864f359cadf3e1550962fcc4127",
      "name": "cognition",
      "namespace": "GO"
    },
    {
      "bel": "complex(a(CHEBI:phospholipid), p(HGNC:SNCA))",
      "function": "Complex",
      "id": "37f4e78f4e1a19554d32aaac6fea66dffac068e498965a385b655245016ee0a7fee1451d8be8f0d9950b4a858cbb242b7349f92208217146aa6f01b9bdf9da38",
      "members": [
        {
          "bel": "a(CHEBI:phospholipid)",
          "function": "Abundance",
          "id": "059b31b0fcdfbb214b0e54d633c669f863f64083c7c8f10e294c0a7ce61e436804ab8d9283481a98ea92c40aaea4b3ff4aec7a95824a8f4a292bd2094f75eba4",
          "name": "phospholipid",
          "namespace": "CHEBI"
        },
        {
          "bel": "p(HGNC:SNCA)",
          "function": "Protein",
          "id": "4345441d1f420dc0d830377737dba9467f21b1637ed3472a697534ce698f2566b780dd52cda47c96b782242b1bcfa70e9a6147fb3bb251d1f3e1e2a0bb7038f3",
          "name": "SNCA",
          "namespace": "HGNC"
        }
      ]
    },
    {
      "bel": "complex(a(GO:microtubule), p(HGNC:MAPT))",
      "function": "Complex",
      "id": "d7f2684793c3c1a57485b55fb8f794739e78d15404986239556841672a48127c8ba3d10a4d9c685163f7442d36972062fdc0329cb3373c4d2cc787e67c185da0",
      "members": [
        {
          "bel": "a(GO:microtubule)",
          "function": "Abundance",
          "id": "0c753f37efe0eb149a47a1dd700eda093a03b462374275c68480b6aed3be0f81aa9793a179dfd97f8e0834f1fb9be4b4a6cff2165b176d9e8a8744f5e0d5bc2c",
          "name": "microtubule",
          "namespace": "GO"
        },
        {
          "bel": "p(HGNC:MAPT)",
          "function": "Protein",
          "id": "ad82d360f02888e890bb2d1f91d1dc020c21cebed2b4eed0193a58e6b396b5f0797d607568dea382c05ffe2a003537d10190b020739af8d51c8d7dbc19bf5ab1",
          "name": "MAPT",
          "namespace": "HGNC"
        }
      ]
    },
    {
      "bel": "complex(p(CONSO:\"VQIVYK motif\"), p(CONSO:\"VQIVYK motif\"))",
      "function": "Complex",
      "id": "bd7bb4ccde140a9ee0b3d6376f3092b497447e2cc692bcca7b3ee57f85d5cc39eb23a33ee50640638de9dc99e368411952e472a52ac43e88a0f6d8adb285c8c3",
      "members": [
        {
          "bel": "p(CONSO:\"VQIVYK motif\")",
          "function": "Protein",
          "id": "687e6d78c01965f7457a9da85a087fd59213b9a1914c689b4054a3cc6e36a9a20ae68d2adadf04b925fcd5fc77cc9fe4a92f3c3515a276723328019437f70c3e",
          "name": "VQIVYK motif",
          "namespace": "CONSO"
        },
        {
          "bel": "p(CONSO:\"VQIVYK motif\")",
          "function": "Protein",
          "id": "687e6d78c01965f7457a9da85a087fd59213b9a1914c689b4054a3cc6e36a9a20ae68d2adadf04b925fcd5fc77cc9fe4a92f3c3515a276723328019437f70c3e",
          "name": "VQIVYK motif",
          "namespace": "CONSO"
        }
      ]
    },
    {
      "bel": "complex(p(HGNC:SNCA), p(HGNC:SNCA))",
      "function": "Complex",
      "id": "5b43376ec207b0b31069e8151607916f4a021de33f6633cdd5f0e71bd4b88d9fa2e9a1eee4e9518a0e99341e697a89a08ca9a67af082ed9eb31656d60d4daf32",
      "members": [
        {
          "bel": "p(HGNC:SNCA)",
          "function": "Protein",
          "id": "4345441d1f420dc0d830377737dba9467f21b1637ed3472a697534ce698f2566b780dd52cda47c96b782242b1bcfa70e9a6147fb3bb251d1f3e1e2a0bb7038f3",
          "name": "SNCA",
          "namespace": "HGNC"
        },
        {
          "bel": "p(HGNC:SNCA)",
          "function": "Protein",
          "id": "4345441d1f420dc0d830377737dba9467f21b1637ed3472a697534ce698f2566b780dd52cda47c96b782242b1bcfa70e9a6147fb3bb251d1f3e1e2a0bb7038f3",
          "name": "SNCA",
          "namespace": "HGNC"
        }
      ]
    },
    {
      "bel": "complex(p(HGNC:SNCA), p(HGNC:VAMP2))",
      "function": "Complex",
      "id": "a7a7ff4e20f2a6171510eb4c614db111506652f1e95b3c8c9a65044c0bd6074a4def5e012ae16060fcb89bad8d23291c4c2c8d9adcd60df440bc99163ffd0d7f",
      "members": [
        {
          "bel": "p(HGNC:SNCA)",
          "function": "Protein",
          "id": "4345441d1f420dc0d830377737dba9467f21b1637ed3472a697534ce698f2566b780dd52cda47c96b782242b1bcfa70e9a6147fb3bb251d1f3e1e2a0bb7038f3",
          "name": "SNCA",
          "namespace": "HGNC"
        },
        {
          "bel": "p(HGNC:VAMP2)",
          "function": "Protein",
          "id": "6c818f2d1362dbe865916238b9aea3c674022e87405ca8d0885ca53bbed181fa985f4210f8e45ae315b34295961a08e888279c8dfcf1ec556278c702fbc342cf",
          "name": "VAMP2",
          "namespace": "HGNC"
        }
      ]
    },
    {
      "bel": "p(CONSO:\"Tau isoform F (441 aa)\")",
      "function": "Protein",
      "id": "00367ae0b38226280c90b32288fd8cc4ecc717167adaf7bee9c0a1afbb03387cafb6392a4e3f7b533e88d728f63336cc06559af4651793e7b8fac417375e5274",
      "name": "Tau isoform F (441 aa)",
      "namespace": "CONSO"
    },
    {
      "bel": "p(CONSO:\"Tau isoform F (441 aa)\", pmod(CONSO:\"O-GlcNAcylation\"))",
      "function": "Protein",
      "id": "c39321853ef28388aec61f43cf224c9e29303c8920c8d820c63620ee0783c299dd6b0a7d7510722dbb43b4cddbe819c391e59559608fbbfc24a457e4c20abc2f",
      "name": "Tau isoform F (441 aa)",
      "namespace": "CONSO",
      "variants": [
        {
          "identifier": {
            "name": "O-GlcNAcylation",
            "namespace": "CONSO"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(CONSO:\"VQIVYK motif\")",
      "function": "Protein",
      "id": "687e6d78c01965f7457a9da85a087fd59213b9a1914c689b4054a3cc6e36a9a20ae68d2adadf04b925fcd5fc77cc9fe4a92f3c3515a276723328019437f70c3e",
      "name": "VQIVYK motif",
      "namespace": "CONSO"
    },
    {
      "bel": "p(CONSO:\"VQIVYK motif\", pmod(CONSO:\"O-GlcNAcylation\"))",
      "function": "Protein",
      "id": "01c6a957b8151650017f73df7ecefb2137cc17e7e80e938f91b20d4e9ba2ecf4e32cf6b0b9751863be5d5597ec17123d9ac2043723d5ab865a6264fa06d94a5b",
      "name": "VQIVYK motif",
      "namespace": "CONSO",
      "variants": [
        {
          "identifier": {
            "name": "O-GlcNAcylation",
            "namespace": "CONSO"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(CONSO:\"alpha-synuclein fibrils\")",
      "function": "Protein",
      "id": "b99f6a3aeab012daf8604be9053ce3315d449ebfb4d91fbc30aa2d1baeed6d2d946ea21d052732274504e4705aa9985ba1d3116d341bd26db33e0e8f78d33ec5",
      "name": "alpha-synuclein fibrils",
      "namespace": "CONSO"
    },
    {
      "bel": "p(CONSO:\"alpha-synuclein fibrils\", frag(\"?\"))",
      "function": "Protein",
      "id": "05c26df464844f8d581692f18aa794357479d8e509275133415572206563d93aac5aa7d509ee26a7ce19478e7de10d777bf198096e3a3286320a84fdc14c1e02",
      "name": "alpha-synuclein fibrils",
      "namespace": "CONSO",
      "variants": [
        {
          "kind": "frag",
          "missing": "?"
        }
      ]
    },
    {
      "bel": "p(CONSO:\"sAPP-alpha\")",
      "function": "Protein",
      "id": "ed93b0dc34eaef3af160558aee0b3a7ddac2727804ae9edba36ae15828b0209345d1f55a65b19b68604395ec17d3900de157f1a39fd6519540b3d4f3d48d475e",
      "name": "sAPP-alpha",
      "namespace": "CONSO"
    },
    {
      "bel": "p(FPLX:AKT)",
      "function": "Protein",
      "id": "3263678a1e320013081e7134e7e64e91b2c66e6fbd10dd7fe4fd282cf0cc3ba29b5cacb5e8eb0a8ac0a194f73b80dabcea5465b0fec5b044290b259ba889cef1",
      "name": "AKT",
      "namespace": "FPLX"
    },
    {
      "bel": "p(FPLX:AKT, pmod(Ph))",
      "function": "Protein",
      "id": "e0ee1c0157a2e80e92de9745508ee6e818136d101d39c7f9a2c0a61ce4155bb1dee984ecee4d3f153cee55b87c5821b182f32bf6c394fb20beb507e6b337499d",
      "name": "AKT",
      "namespace": "FPLX",
      "variants": [
        {
          "identifier": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(HGNC:APP)",
      "function": "Protein",
      "id": "ed1d45f3255226e4210017e6c179950e0e04a300727326d7fea6a9659868e8818ff64fd5e8a2a92a703fb1566b3f48323750ac6c28e7adb40843053d276710bc",
      "name": "APP",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:APP, frag(\"?\"))",
      "function": "Protein",
      "id": "0cd030feee61d24509f1113cd1a21235abc2d2ea5e708eee393187b282274b4611a6b84fbe441e827bb24baad54f8701bd724f8fc4439f01f041368f8783abf8",
      "name": "APP",
      "namespace": "HGNC",
      "variants": [
        {
          "kind": "frag",
          "missing": "?"
        }
      ]
    },
    {
      "bel": "p(HGNC:APP, pmod(CONSO:\"O-GlcNAcylation\"))",
      "function": "Protein",
      "id": "7948e7c17a85576328127ab79e1d9a3758661aaa35ed6243ce4120bee69607a97c9a86bea51e905c92488038f64d92e549b1018a217f28744533f681a1ace38e",
      "name": "APP",
      "namespace": "HGNC",
      "variants": [
        {
          "identifier": {
            "name": "O-GlcNAcylation",
            "namespace": "CONSO"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(HGNC:BDNF)",
      "function": "Protein",
      "id": "5bbeeb6a1045d125bd5495fbff1f4831c8697d0b4f9b77ff9f1127fd8bcf4d96eda74adab4e84332c6c9ba5bb97e102771278841e902a126ddbb438fddf7b8be",
      "name": "BDNF",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:HTT)",
      "function": "Protein",
      "id": "f3dac0d39a258f730f45800014166f0cd6e8002b0bd1f9be6aefa0958d84dc3a67a48721743405568d2c7942ea831f7bdc6cdcc7a990bb1a7d5161351e6e67b0",
      "name": "HTT",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:HTT, pmod(CONSO:\"O-GlcNAcylation\"))",
      "function": "Protein",
      "id": "bc111909413bab717cdd739529ec8174b9ad977cbc6bf47803d975ae5494fa18e9a0d59f95a40aa3ec9b6be03d805889acf24cb7903eb3b8208f6eabede58cbf",
      "name": "HTT",
      "namespace": "HGNC",
      "variants": [
        {
          "identifier": {
            "name": "O-GlcNAcylation",
            "namespace": "CONSO"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(HGNC:HTT, var(\"?\"))",
      "function": "Protein",
      "id": "ecfea6b35e9ef56154b1f7d1255c3ae63e48c14c262428a01170245d2ffae3786b0b2439c3b2b1f6abf506d5ff2a338d6de2d7a2c18ee7defc89d51c50e22f75",
      "name": "HTT",
      "namespace": "HGNC",
      "variants": [
        {
          "identifier": "?",
          "kind": "hgvs"
        }
      ]
    },
    {
      "bel": "p(HGNC:MAPT)",
      "function": "Protein",
      "id": "ad82d360f02888e890bb2d1f91d1dc020c21cebed2b4eed0193a58e6b396b5f0797d607568dea382c05ffe2a003537d10190b020739af8d51c8d7dbc19bf5ab1",
      "name": "MAPT",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:MAPT, pmod(CONSO:\"O-GlcNAcylation\"))",
      "function": "Protein",
      "id": "bab368c52cafe5d77b878d7d86fddbc9733817e5e522b34e447a0b714b0801972f01f208b959d5e6129872aa15d8d75a3463e147366870276d232f909d7f7e49",
      "name": "MAPT",
      "namespace": "HGNC",
      "variants": [
        {
          "identifier": {
            "name": "O-GlcNAcylation",
            "namespace": "CONSO"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(HGNC:MAPT, pmod(CONSO:\"O-GlcNAcylation\", Ser, 400))",
      "function": "Protein",
      "id": "a50efb2ff3562e4ea2457aade8fac1c83c4907a1ad3bdd33b69ec9fc81f1827d32f4396d1712a57f1f5d5f65f149134b31ed876cfa52634e2969452fa71bf54f",
      "name": "MAPT",
      "namespace": "HGNC",
      "variants": [
        {
          "code": "Ser",
          "identifier": {
            "name": "O-GlcNAcylation",
            "namespace": "CONSO"
          },
          "kind": "pmod",
          "pos": 400
        }
      ]
    },
    {
      "bel": "p(HGNC:MAPT, pmod(CONSO:hyperphosphorylation))",
      "function": "Protein",
      "id": "166f8ffaf3545bdd3b53ffa10d71424d13fe887cfe8c23c5a14c37fa8690edfcceae513eb8617518628e37b383d8532386c712cd713106884fe9af24e429036a",
      "name": "MAPT",
      "namespace": "HGNC",
      "variants": [
        {
          "identifier": {
            "name": "hyperphosphorylation",
            "namespace": "CONSO"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(HGNC:MAPT, pmod(Ph))",
      "function": "Protein",
      "id": "526bae251987f8c4f55f6e2451662fa55e087c57585beae7c389b020d73487c739834e9b8ec841783de6a5b5fb9df8b138e9eff4406a9ec5e606766575dcac0e",
      "name": "MAPT",
      "namespace": "HGNC",
      "variants": [
        {
          "identifier": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(HGNC:MAPT, pmod(Ph, Ser, 396))",
      "function": "Protein",
      "id": "233ebce30d7505cee42acc956f9d268e5b725e14853bd56fab3b87a93a4e0c8141a6fdec062d10e9c4924f6e13a61184600872c2f5080656e3ca27227eb4cb93",
      "name": "MAPT",
      "namespace": "HGNC",
      "variants": [
        {
          "code": "Ser",
          "identifier": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod",
          "pos": 396
        }
      ]
    },
    {
      "bel": "p(HGNC:MAPT, pmod(Ph, Thr, 231))",
      "function": "Protein",
      "id": "fd67fbe5c0c0911e8bffaf415eb40748a781d8776f2e2cdf8a3f4f97f0f2f312aaa680c7b670dc27b11d220f0079b4d5e41cbcf095a568bc644b6e9eaefc50b3",
      "name": "MAPT",
      "namespace": "HGNC",
      "variants": [
        {
          "code": "Thr",
          "identifier": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod",
          "pos": 231
        }
      ]
    },
    {
      "bel": "p(HGNC:MTOR)",
      "function": "Protein",
      "id": "4295eeb1bbce42b573aab8558d259ce748cbe0e654d937c271988dcbccadf88e9ca956ccb7b3c3b1e44d70554b4f4a54e83eec0d411d6ef25631920ca14f6789",
      "name": "MTOR",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:MTOR, pmod(Ph))",
      "function": "Protein",
      "id": "30c5615b45480c1362e018d6252d11cf516d43941ef0cb3825ace613a49c22fc251ddb16d7bd087d9848c243f1bffc946355fca3ee0c1c4ade5d319ad644fd2a",
      "name": "MTOR",
      "namespace": "HGNC",
      "variants": [
        {
          "identifier": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(HGNC:OGA)",
      "function": "Protein",
      "id": "70112cfa39e7f9e64515734dae8cbb9d9c5e6e59ce1a66837851a54fffd09e795a99ec1aac520290ebd1de2494896350e154af05c3760ec1cf40c68697f8a001",
      "name": "OGA",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:OGT)",
      "function": "Protein",
      "id": "42b08de710261c95b148ed72f0b3c3878d6bfc3da9088e297805e4b4a4540d1ae49e17467ff65f3a47e831a16f7628b33f54614e5f8d5709e4f2b4027e4bc366",
      "name": "OGT",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:SNCA)",
      "function": "Protein",
      "id": "4345441d1f420dc0d830377737dba9467f21b1637ed3472a697534ce698f2566b780dd52cda47c96b782242b1bcfa70e9a6147fb3bb251d1f3e1e2a0bb7038f3",
      "name": "SNCA",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:SNCA, frag(\"68_77\"))",
      "function": "Protein",
      "id": "aeacc74e639fefe3fd7d6838a4a1be58abc8e33854ec10b043888a4787f9f7f9cbb34b758eab5ed06eb8a5bbf080791872b41a942417f439912d670e6a7dfc14",
      "name": "SNCA",
      "namespace": "HGNC",
      "variants": [
        {
          "kind": "frag",
          "start": 68,
          "stop": 77
        }
      ]
    },
    {
      "bel": "p(HGNC:SNCA, frag(\"?\"))",
      "function": "Protein",
      "id": "bf9106f403a6987552600db2eb76426d8e6dd196bb7e943ee82c95c60bc16afc2f1357237011d6844ead86a4f9d0e78ec162ab52e3fc901d3baf8fb37e86ce01",
      "name": "SNCA",
      "namespace": "HGNC",
      "variants": [
        {
          "kind": "frag",
          "missing": "?"
        }
      ]
    },
    {
      "bel": "p(HGNC:SNCA, frag(\"?_*\"))",
      "function": "Protein",
      "id": "25bc8e8199c592c47a3b0ef847fe153106b18dbd146e8a19807aaaa83be3971a4b08077a417ef0b6b9958d507d59a7e336159edd8eb9a9b36e43e8ffbbb43a6f",
      "name": "SNCA",
      "namespace": "HGNC",
      "variants": [
        {
          "kind": "frag",
          "start": "?",
          "stop": "*"
        }
      ]
    },
    {
      "bel": "p(HGNC:SNCA, pmod(CONSO:\"O-GlcNAcylation\"))",
      "function": "Protein",
      "id": "dc73a172fcd4260e8b7c5571af8d4d90233b5836db5e676829b599773321507ed61130eb872c26aea00a10b135516578f2c358b05b5d8ba9a78b5a473de69893",
      "name": "SNCA",
      "namespace": "HGNC",
      "variants": [
        {
          "identifier": {
            "name": "O-GlcNAcylation",
            "namespace": "CONSO"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(HGNC:SNCA, pmod(CONSO:\"O-GlcNAcylation\", Ser, 87))",
      "function": "Protein",
      "id": "05d102d39364ffe433ac44afc23d0097f40ca10a88d66b2561f2ef1de489a2ed57a8e94e57414e09ba1a6423d37420fafef452e0a2d0dcabcdf6f37efe66d545",
      "name": "SNCA",
      "namespace": "HGNC",
      "variants": [
        {
          "code": "Ser",
          "identifier": {
            "name": "O-GlcNAcylation",
            "namespace": "CONSO"
          },
          "kind": "pmod",
          "pos": 87
        }
      ]
    },
    {
      "bel": "p(HGNC:SNCA, pmod(CONSO:\"O-GlcNAcylation\", Ser, 87), pmod(CONSO:\"O-GlcNAcylation\", Thr, 75), pmod(CONSO:\"O-GlcNAcylation\", Thr, 81))",
      "function": "Protein",
      "id": "ad506a5e123a43af88b9454bdbb0ee64b8f4b1aac3e354162de3e365b5dd70ede013c9d995e29207f47be7b475463f67dd913fd33d12871cc119dfd437e16887",
      "name": "SNCA",
      "namespace": "HGNC",
      "variants": [
        {
          "code": "Ser",
          "identifier": {
            "name": "O-GlcNAcylation",
            "namespace": "CONSO"
          },
          "kind": "pmod",
          "pos": 87
        },
        {
          "code": "Thr",
          "identifier": {
            "name": "O-GlcNAcylation",
            "namespace": "CONSO"
          },
          "kind": "pmod",
          "pos": 75
        },
        {
          "code": "Thr",
          "identifier": {
            "name": "O-GlcNAcylation",
            "namespace": "CONSO"
          },
          "kind": "pmod",
          "pos": 81
        }
      ]
    },
    {
      "bel": "p(HGNC:SNCA, pmod(CONSO:\"O-GlcNAcylation\", Thr, 72))",
      "function": "Protein",
      "id": "7a5fa7b675d00fd558c9c8421f873da8ca3e0e45ff18ae53496f0f74c05d9ddd3f7d717aff65aba3b30727bfeed9d049640413b1cd7319ac02f3f86a0e3bbfed",
      "name": "SNCA",
      "namespace": "HGNC",
      "variants": [
        {
          "code": "Thr",
          "identifier": {
            "name": "O-GlcNAcylation",
            "namespace": "CONSO"
          },
          "kind": "pmod",
          "pos": 72
        }
      ]
    },
    {
      "bel": "p(HGNC:SNCA, pmod(CONSO:\"O-GlcNAcylation\", Thr, 75))",
      "function": "Protein",
      "id": "e7663e188573986ac507a010a7295248c9b62b4ed11b3e24dfd8e667ce87a99896b2f9f969708927fbf958a759a7bee2a030f2805dc8cd7b52f56038876973cb",
      "name": "SNCA",
      "namespace": "HGNC",
      "variants": [
        {
          "code": "Thr",
          "identifier": {
            "name": "O-GlcNAcylation",
            "namespace": "CONSO"
          },
          "kind": "pmod",
          "pos": 75
        }
      ]
    },
    {
      "bel": "p(HGNC:SNCA, pmod(CONSO:\"O-GlcNAcylation\", Thr, 81))",
      "function": "Protein",
      "id": "a4fdadc3cc9148c740561ef4ed45670149dac65b4559ffa98a450e5c4a158b4783c6e5f2def9f73b3edcefc5fe781786e4560feb568fac3f72b97eb1534e7bfd",
      "name": "SNCA",
      "namespace": "HGNC",
      "variants": [
        {
          "code": "Thr",
          "identifier": {
            "name": "O-GlcNAcylation",
            "namespace": "CONSO"
          },
          "kind": "pmod",
          "pos": 81
        }
      ]
    },
    {
      "bel": "p(HGNC:SNCA, pmod(Ph))",
      "function": "Protein",
      "id": "97394fdd35c1047ca232cf6a6bfaa8e991294c25a2d8e46bd3bbea9595703a8ee4c40bf39459ba6cf9eef8706e5367f4392ac005265c20eaaae0c608a9c9fbb8",
      "name": "SNCA",
      "namespace": "HGNC",
      "variants": [
        {
          "identifier": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(HGNC:SNCA, var(\"?\"))",
      "function": "Protein",
      "id": "0d646c2b44d28c4acc9f9df1e5691d8250fda5b35ec7b7818be264cf143fdd8a975666a0e67d14bea4130c53464dfafa710e2c65f54a7fdc0151fc726740f440",
      "name": "SNCA",
      "namespace": "HGNC",
      "variants": [
        {
          "identifier": "?",
          "kind": "hgvs"
        }
      ]
    },
    {
      "bel": "p(HGNC:SOD1)",
      "function": "Protein",
      "id": "7bebe84ddc870a4ceb70828bba41ec797b861126138342942eb8124edaef94657501d4b9c4a69876b38e0fba2ff4cd5a91b560173b73723f03809ed503e90e98",
      "name": "SOD1",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:SOD1, var(\"?\"))",
      "function": "Protein",
      "id": "489d0def821169265e7e27a156e90cfceba86c9192b2566cc767f80dfba25e8f19d858d93667e7c8280bca5e41c8b63db9c5e590b43bc6d0b9039bcb9afbba00",
      "name": "SOD1",
      "namespace": "HGNC",
      "variants": [
        {
          "identifier": "?",
          "kind": "hgvs"
        }
      ]
    },
    {
      "bel": "p(HGNC:VAMP2)",
      "function": "Protein",
      "id": "6c818f2d1362dbe865916238b9aea3c674022e87405ca8d0885ca53bbed181fa985f4210f8e45ae315b34295961a08e888279c8dfcf1ec556278c702fbc342cf",
      "name": "VAMP2",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNCGENEFAMILY:Calpains)",
      "function": "Protein",
      "id": "6f97880ba837b68d16ab00a1ee99ec9158dcf80bd4e3a4b320928099280c570081c6583584961ae19d42bdf033d46a1fe95bca799ce09113da082a06b5c64555",
      "name": "Calpains",
      "namespace": "HGNCGENEFAMILY"
    },
    {
      "bel": "p(MESH:Proteins)",
      "function": "Protein",
      "id": "20fec9748aca569e46ee2703620f548aece50dde1dd6518d2833a58da6a5fc28e70918b127d515943ad659b626fa533df7854b4887e2cab8d3a7af00dea602d0",
      "name": "Proteins",
      "namespace": "MESH"
    },
    {
      "bel": "p(MESH:Proteins, pmod(CONSO:\"O-GlcNAcylation\"))",
      "function": "Protein",
      "id": "0c4af02aa47f67fdd36d8a37f530866d6546df1fcee562e4d82dfb054cacbadc8dbfb461fbb39349b6c133f4ed3db4fbf3faf95533bae3f7ad743a3eb802921b",
      "name": "Proteins",
      "namespace": "MESH",
      "variants": [
        {
          "identifier": {
            "name": "O-GlcNAcylation",
            "namespace": "CONSO"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(MGI:Mapt)",
      "function": "Protein",
      "id": "7d94454106658b1e4190b417a419f7ccbab4b525157cd679cbb4da8a006b08c3819b0a360b692358b3f80ea2648890248be2aa7c97e1d59962dc6aa097560f2d",
      "name": "Mapt",
      "namespace": "MGI"
    },
    {
      "bel": "p(MGI:Mapt, pmod(CONSO:\"O-GlcNAcylation\"))",
      "function": "Protein",
      "id": "7e161e4a8e705b7ce4a90c86f93ec12280ed4550aab4b59efecd356ba2f157e5c6ccb0de3f0ca0fee40e36cc6e7aa51f3e24ca60ef5392d012b0b51750ab9d52",
      "name": "Mapt",
      "namespace": "MGI",
      "variants": [
        {
          "identifier": {
            "name": "O-GlcNAcylation",
            "namespace": "CONSO"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(MGI:Mapt, pmod(CONSO:hyperphosphorylation))",
      "function": "Protein",
      "id": "b34e093998180b3976865dd766b707451ab8ccfd6e4531877897de1fc1686be19e449c5d0d32ec8c9f205bde40141e912a0deefcf6aa9e26e496aaeeb2359083",
      "name": "Mapt",
      "namespace": "MGI",
      "variants": [
        {
          "identifier": {
            "name": "hyperphosphorylation",
            "namespace": "CONSO"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(MGI:Mapt, pmod(Ph))",
      "function": "Protein",
      "id": "866eb2548d3ebb8c575db22b2dbbed794da750619a04d31b30c8ffbd59b1562d89d2191f4ea30cc09874d9d44f251a203918593f4cc4e29a12eb1d52d0f58bd4",
      "name": "Mapt",
      "namespace": "MGI",
      "variants": [
        {
          "identifier": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(MGI:Mapt, pmod(Ph, Ser, 202), pmod(Ph, Ser, 205))",
      "function": "Protein",
      "id": "704361a51e309e6d7d7259217a6a36130d0697a68b0cf9ad653bd9053a58be1beee3af1b9e29529aab449a6714f3eadf6e45bb14b8917512ce5d97b13e8fdb64",
      "name": "Mapt",
      "namespace": "MGI",
      "variants": [
        {
          "code": "Ser",
          "identifier": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod",
          "pos": 202
        },
        {
          "code": "Ser",
          "identifier": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod",
          "pos": 205
        }
      ]
    },
    {
      "bel": "p(MGI:Mapt, pmod(Ph, Ser, 356))",
      "function": "Protein",
      "id": "c7c601a00fbfe9d06d3664a903edfb06331301369b9bdb641baaff8fbe15c57d91d445881bc7feee4acd9947918547ff33f77c962bc5a797d2de330ecadebadf",
      "name": "Mapt",
      "namespace": "MGI",
      "variants": [
        {
          "code": "Ser",
          "identifier": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod",
          "pos": 356
        }
      ]
    },
    {
      "bel": "p(MGI:Mapt, pmod(Ph, Ser, 396))",
      "function": "Protein",
      "id": "69b41bb93945901dccbb1dcfd9330ab59edc188609471d780f4b5edf6ef9d2256e20f679d1dd3266da2c2fa35e123f4c6c797463f998a780c57daba53fc4fea1",
      "name": "Mapt",
      "namespace": "MGI",
      "variants": [
        {
          "code": "Ser",
          "identifier": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod",
          "pos": 396
        }
      ]
    },
    {
      "bel": "p(MGI:Mapt, pmod(Ph, Ser, 400))",
      "function": "Protein",
      "id": "a06fd6358cf1d994fe598c9d6eee64d552d1c744f65f91283f0175ef145154046d8636ec13630c2bebd8a29897bddf707c13d7111d65417a77e57d4e396d3298",
      "name": "Mapt",
      "namespace": "MGI",
      "variants": [
        {
          "code": "Ser",
          "identifier": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod",
          "pos": 400
        }
      ]
    },
    {
      "bel": "p(MGI:Mapt, pmod(Ph, Ser, 626))",
      "function": "Protein",
      "id": "7644a268cee0d05132ef5dafede0d38011b4e02b72daecc980164ef437457cb873e74fbe161de3c41a95197a0dbeedd55e27a01d1ab8e6538133e06ffcd96207",
      "name": "Mapt",
      "namespace": "MGI",
      "variants": [
        {
          "code": "Ser",
          "identifier": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod",
          "pos": 626
        }
      ]
    },
    {
      "bel": "p(MGI:Oga)",
      "function": "Protein",
      "id": "f5d64e7a620f7aa630a3766c8d2ebc2f93b5bcf46788a71049d2b781929d4389b34e4a4031cbdb49181c83fb9b8ee79a85391331c2a83599e8d1bf9ad2f92809",
      "name": "Oga",
      "namespace": "MGI"
    },
    {
      "bel": "p(MGI:Sod1)",
      "function": "Protein",
      "id": "0a0c9eb82637c52ee1684eb1c168066ccb246f388999f4a9d70ce6b8c4d3296eec80fda9b3bd9bcbd820baf3d49cef02f48843b7d1c5d9000600d3a984aa2df3",
      "name": "Sod1",
      "namespace": "MGI"
    },
    {
      "bel": "p(MGI:Sod1, pmod(CONSO:\"O-GlcNAcylation\"))",
      "function": "Protein",
      "id": "4f56184a311296fd8af93f7317e55b38ffa304c1ae8fa1804625ccd7cdc640019d88ec1aa8d06ce56108a4e74d7fa96a98871e8ecd800f7d26af02fb8175ee0b",
      "name": "Sod1",
      "namespace": "MGI",
      "variants": [
        {
          "identifier": {
            "name": "O-GlcNAcylation",
            "namespace": "CONSO"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(MGI:Sod1, var(\"?\"))",
      "function": "Protein",
      "id": "079d3563e35db5a199d9b32baf875021c4a807e10013d0b2a9b8cb58fafafe0b3728fa0d1026c1f7ab344c98ac5d5b840bc6a8c16fa4f514bfb9e980accba2a4",
      "name": "Sod1",
      "namespace": "MGI",
      "variants": [
        {
          "identifier": "?",
          "kind": "hgvs"
        }
      ]
    },
    {
      "bel": "p(RGD:Mapt)",
      "function": "Protein",
      "id": "d7ee72cc866dbe8148a83717b5c56b67f46b715c1c11fac47257b38efabf4f3947f73dc4a227db3e8e7a2039b162b0b1b1bbb0d7605e6e651f1dba7fedfc3bd4",
      "name": "Mapt",
      "namespace": "RGD"
    },
    {
      "bel": "p(RGD:Mapt, pmod(CONSO:\"O-GlcNAcylation\"))",
      "function": "Protein",
      "id": "358ffdaa44097c68a60e186eecd66191cb182468a332dbbdf2ad00faf32cb077ed7a24b0a7cf779bf5cd50d8d5678f3ff93b642beb4f92aaac087dee7f2a5237",
      "name": "Mapt",
      "namespace": "RGD",
      "variants": [
        {
          "identifier": {
            "name": "O-GlcNAcylation",
            "namespace": "CONSO"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(RGD:Mapt, pmod(Ph))",
      "function": "Protein",
      "id": "3b0967909beeb3e40181b42fd6d8b686507dc30354899f69d27bf9a7ea2017d23c8c8eacece7f76cec5a6edf1718c6a64dcbe256459eaf7543b8049d477f0c96",
      "name": "Mapt",
      "namespace": "RGD",
      "variants": [
        {
          "identifier": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(RGD:Mapt, pmod(Ph, Ser, 396))",
      "function": "Protein",
      "id": "744bfea9f94f4f19a58d6c25effeb7f01a939815eda28815374fdcdabe7e3401a49ebcf69a608f91ea328bcd2356ea45069e6c42e9fd28cf5979bcdc268e34e7",
      "name": "Mapt",
      "namespace": "RGD",
      "variants": [
        {
          "code": "Ser",
          "identifier": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod",
          "pos": 396
        }
      ]
    },
    {
      "bel": "p(RGD:Mapt, pmod(Ph, Ser, 422))",
      "function": "Protein",
      "id": "9435b4f65f5873ee53933f91c6fa871db34598e90e1bec2c1bbc74662633dd589627d3599480d67f40036bb7f99130b73c73cb0e6df19195eaa3162ba65d21ba",
      "name": "Mapt",
      "namespace": "RGD",
      "variants": [
        {
          "code": "Ser",
          "identifier": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod",
          "pos": 422
        }
      ]
    },
    {
      "bel": "p(RGD:Mapt, pmod(Ph, Thr, 231))",
      "function": "Protein",
      "id": "3fb25b1a41e40568bdc8b0d5f7eaca362986d336d37d480f31bf2ec2b93316307929f2bf2ce8046613acbfce0f0171d2bf62c710bb6571edd28a2f9cda3ad4ae",
      "name": "Mapt",
      "namespace": "RGD",
      "variants": [
        {
          "code": "Thr",
          "identifier": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod",
          "pos": 231
        }
      ]
    },
    {
      "bel": "p(RGD:Oga)",
      "function": "Protein",
      "id": "c3ea3c7642ccc5326dc1bc9c4bd7b36ff5077884bb4ec28961ddc73afb5caf5cfad7b0bbd94ca1de995f59dbc87091cfcd613414d29e27ab3adca2c92f52f9ad",
      "name": "Oga",
      "namespace": "RGD"
    },
    {
      "bel": "path(HP:\"Postural instability\")",
      "function": "Pathology",
      "id": "70b5c945e50c584c02ecfbe670bc07db497f895abed0158cdd8344da543183c466225a3d894cd2db475c6100df48e5eb180c82125550a36cfcf99aec5ad797fa",
      "name": "Postural instability",
      "namespace": "HP"
    },
    {
      "bel": "path(MESH:\"Alzheimer Disease\")",
      "function": "Pathology",
      "id": "00f72839b5d655cb4cb088b0eb8874bd406284d98a2afd0bdd73de0a34adb78af374b0eb26990387f41d3b41cda0e32c1b5ff5f86ed63d0fdc841bac17865541",
      "name": "Alzheimer Disease",
      "namespace": "MESH"
    },
    {
      "bel": "path(MESH:\"Amyotrophic Lateral Sclerosis\")",
      "function": "Pathology",
      "id": "5e56d7b5172af0ae281c2f920b132d7b2263ae5eff7b0f1c9a22347914d8c169c79314aa7738c7e68cf75fac198de894bff58cb9fd4a0cb95ab434310fa07daa",
      "name": "Amyotrophic Lateral Sclerosis",
      "namespace": "MESH"
    },
    {
      "bel": "path(MESH:\"Muscle Rigidity\")",
      "function": "Pathology",
      "id": "ae0609aa1c5bd187eff52a2d7c1f1e3b94cfe46697bbc7ea034dabbd6677b0c9657c2dcf14675bede221fa6d89ce720d7c6d4d30640526e411091c405ffe2960",
      "name": "Muscle Rigidity",
      "namespace": "MESH"
    },
    {
      "bel": "path(MESH:\"Parkinson Disease\")",
      "function": "Pathology",
      "id": "d7f039170f83b3fcc27595412f3b0352cd1fe95f8481a2b1144ce311ac81bb5f0087a0a7e682f498d193e00b8e8fb29908a6e0b8e23da5ef349aeeb4723b9be0",
      "name": "Parkinson Disease",
      "namespace": "MESH"
    },
    {
      "bel": "path(MESH:Gliosis)",
      "function": "Pathology",
      "id": "46d8ab84a7ce6995389ca278324930486e96f976926c8cc7fe6a9d293d79524be3010be1e4a9cb2975094b5fe03efce5bb8a536051d0ca1cb100da38c5f62c6f",
      "name": "Gliosis",
      "namespace": "MESH"
    },
    {
      "bel": "path(MESH:Hyperglycemia)",
      "function": "Pathology",
      "id": "9e02f07c8f5a2672919d0531bbe49103611be330425ae84090cf5bc4a928d01ea6531b097186e128f4bd97e008e5bdcedc6ad051267850b427a9ef31da08acc6",
      "name": "Hyperglycemia",
      "namespace": "MESH"
    },
    {
      "bel": "path(MESH:Hypokinesia)",
      "function": "Pathology",
      "id": "13e2bc0fa35f42c3cceffbc516de27b807687fcc4c8d01feda209a081a04e5c3fc0820dc8c611d0d74eb4b3fbb271305f5e32c90f0ec3e9c4ed5ea31b5aa3b78",
      "name": "Hypokinesia",
      "namespace": "MESH"
    },
    {
      "bel": "path(MESH:Inflammation)",
      "function": "Pathology",
      "id": "3196cc4c6a20279c822cae925a9b271d0224f2c8d468e3069a3ee460662be286b61db2f144c550686a9c624e58af4ffa7570f4f2384e1cb8ee40496f8cb3fa5e",
      "name": "Inflammation",
      "namespace": "MESH"
    }
  ]
}